The Healthcare sector includes companies that provide medical services, manufacture medical equipment and drugs, and develop biotechnologies and healthcare solutions. This sector spans a wide range of industries, from pharmaceutical companies and biotechnology firms to healthcare providers, hospitals, and medical device manufacturers. The healthcare sector is considered defensive, as demand for medical care remains constant regardless of the economic environment. Examples include pharmaceutical companies, medical device manufacturers, and healthcare providers.
Sector Read
Coverage Overview
A quick read on breadth, benchmark scope, and data participation.
Median pillar scores with the sector middle band for a quick read on quality, resilience, and valuation posture. Based on 2026.
Growth
Sample 26
Profitability
Sample 26
Health
Sample 26
Efficiency
Sample 26
Valuation
Sample 26
Distribution bands and center points across 1266 contributing companies. Use the tooltip for quartiles, completeness, and freshness, then compare those norms against the leaderboard cards below.
Trend highlights are prioritised around Cash Runway, Operating Margin for this sector.
Latest composite and moat snapshots, plus two sector-relevant benchmark metrics chosen for Healthcare. Tracking Cash Runway and Operating Margin.
Scan scale, positioning, and latest annual metric momentum across the sector without leaving the benchmark view.
| Company | Market Cap | Positioning |
Cash Runway
Latest annual + YoY
|
Operating Margin
Latest annual + YoY
|
|---|---|---|---|---|
|
1.28T
|
Composite
63.2
Moat
42.0
|
-
No YoY
|
6.7%
-9.0
YoY
|
|
|
664.95B
|
Composite
41.2
Moat
66.1
|
-
No YoY
|
27.2%
+3.2
YoY
|
|
|
ABBV
AbbVie Inc.
|
514.92B
|
Composite
45.7
Moat
46.4
|
-
No YoY
|
24.6%
+8.4
YoY
|
|
361.73B
|
Composite
42.1
Moat
66.9
|
-
No YoY
|
34.0%
+2.5
YoY
|
|
|
353.17B
|
Composite
57.7
Moat
63.3
|
-
No YoY
|
4.2%
-3.8
YoY
|
|
|
NVS
Novartis AG
|
308.19B
|
Composite
51.7
Moat
70.4
|
-
No YoY
|
31.1%
+3.0
YoY
|
|
AZN
Astrazeneca PLC
|
289.15B
|
Composite
42.7
Moat
53.0
|
-
No YoY
|
23.4%
+4.9
YoY
|
|
257.42B
|
Composite
60.2
Moat
61.9
|
-
No YoY
|
17.4%
+0.3
YoY
|
|
|
AMGN
Amgen Inc.
|
249.05B
|
Composite
56.4
Moat
54.0
|
-
No YoY
|
24.7%
+3.0
YoY
|
|
207.00B
|
Composite
38.3
Moat
67.7
|
-
No YoY
|
34.0%
+28.3
YoY
|
|
|
190.39B
|
Composite
62.8
Moat
72.8
|
-
No YoY
|
18.2%
+1.9
YoY
|
|
|
NVO
Novo Nordisk A/S
|
177.19B
|
Composite
52.8
Moat
73.9
|
-
No YoY
|
41.3%
-2.9
YoY
|
|
PFE
Pfizer, Inc.
|
167.52B
|
Composite
35.9
Moat
43.3
|
-
No YoY
|
27.8%
+4.3
YoY
|
|
161.99B
|
Composite
64.0
Moat
71.8
|
-
No YoY
|
19.1%
-1.3
YoY
|
|
|
156.96B
|
Composite
63.9
Moat
85.9
|
-
No YoY
|
29.3%
+1.2
YoY
|
|
|
138.71B
|
Composite
66.4
Moat
80.6
|
149.0
No YoY
|
34.8%
+36.9
YoY
|
|
|
MDT
Medtronic plc.
|
134.10B
|
Composite
66.7
Moat
73.1
|
-
No YoY
|
17.8%
+0.0
YoY
|
|
127.02B
|
Composite
50.4
Moat
64.3
|
-
No YoY
|
28.5%
+16.3
YoY
|
|
|
124.06B
|
Composite
67.8
Moat
73.8
|
-
No YoY
|
19.5%
+3.1
YoY
|
|
|
122.48B
|
Composite
48.6
Moat
74.6
|
-
No YoY
|
1.5%
+0.3
YoY
|
|
|
SNY
Sanofi
|
114.41B
|
Composite
39.7
Moat
57.1
|
-
No YoY
|
13.6%
-2.8
YoY
|
|
107.28B
|
Composite
52.2
Moat
59.0
|
-
No YoY
|
1.2%
-1.1
YoY
|
|
|
103.40B
|
Composite
52.4
Moat
70.3
|
-
No YoY
|
15.8%
+0.9
YoY
|
|
|
MRNA
Moderna, Inc.
|
101.48B
|
Composite
52.3
Moat
47.4
|
37.15
+9.1
YoY
|
-1.6%
-0.4
YoY
|
|
GSK
GSK plc
|
100.89B
|
Composite
43.6
Moat
55.1
|
-
No YoY
|
24.3%
+11.5
YoY
|
|
93.55B
|
Composite
65.8
Moat
78.1
|
-
No YoY
|
24.9%
-3.2
YoY
|
|
|
91.96B
|
Composite
48.5
Moat
73.5
|
-
No YoY
|
4.1%
-1.0
YoY
|
|
|
77.36B
|
Composite
42.4
Moat
72.8
|
-
No YoY
|
3.4%
-0.5
YoY
|
|
|
66.18B
|
Composite
59.4
Moat
58.7
|
-
No YoY
|
0.1%
-7.3
YoY
|
|
|
COR
Cencora, Inc.
|
63.65B
|
Composite
56.2
Moat
60.1
|
-
No YoY
|
0.8%
+0.1
YoY
|
|
62.80B
|
Composite
58.9
Moat
66.1
|
-
No YoY
|
1.0%
+0.0
YoY
|
|
|
61.97B
|
Composite
60.4
Moat
76.5
|
-
No YoY
|
18.0%
+2.5
YoY
|
|
|
58.73B
|
Composite
67.2
Moat
77.4
|
-
No YoY
|
20.8%
-4.5
YoY
|
|
|
57.71B
|
Composite
57.2
Moat
63.4
|
-
No YoY
|
11.8%
-0.1
YoY
|
|
|
ARGX
argenx SE
|
56.88B
|
Composite
67.5
Moat
76.1
|
490.0
+399.2
YoY
|
25.4%
+26.4
YoY
|
|
53.26B
|
Composite
63.9
Moat
77.6
|
-
No YoY
|
31.6%
+2.7
YoY
|
|
|
HUM
Humana Inc.
|
52.09B
|
Composite
49.9
Moat
52.0
|
-
No YoY
|
1.1%
-0.3
YoY
|
|
49.72B
|
Composite
57.5
Moat
64.0
|
-
No YoY
|
12.5%
+14.3
YoY
|
|
|
49.27B
|
Composite
62.8
Moat
70.0
|
-
No YoY
|
21.3%
-1.6
YoY
|
|
|
VEEV
Veeva Systems Inc.
|
49.18B
|
Composite
64.2
Moat
88.0
|
-
No YoY
|
28.7%
+3.5
YoY
|
|
ONC
BeiGene, Ltd.
|
46.26B
|
Composite
70.8
Moat
74.8
|
224.2
+191.3
YoY
|
8.4%
+23.3
YoY
|
|
NTRA
Natera, Inc.
|
45.05B
|
Composite
52.5
Moat
54.0
|
42.71
+17.7
YoY
|
-13.4%
-0.3
YoY
|
|
44.96B
|
Composite
61.5
Moat
71.4
|
-
No YoY
|
25.4%
-2.6
YoY
|
|
|
44.80B
|
Composite
57.4
Moat
64.5
|
-
No YoY
|
13.4%
-0.9
YoY
|
|
|
41.59B
|
Composite
55.8
Moat
40.7
|
27.08
-22.2
YoY
|
-42.1%
-34.8
YoY
|
|
|
HLN
Haleon plc
|
39.82B
|
Composite
64.3
Moat
74.6
|
-
No YoY
|
21.9%
+2.2
YoY
|
|
37.25B
|
Composite
54.9
Moat
72.2
|
-
No YoY
|
13.4%
+0.1
YoY
|
|
|
BIIB
Biogen Inc.
|
36.71B
|
Composite
39.1
Moat
60.6
|
-
No YoY
|
25.0%
+1.4
YoY
|
|
ALC
Alcon Inc.
|
36.15B
|
Composite
60.3
Moat
73.3
|
-
No YoY
|
13.1%
-1.2
YoY
|
|
34.53B
|
Composite
33.7
Moat
29.2
|
-
No YoY
|
-3.9%
-5.9
YoY
|
|
|
34.51B
|
Composite
60.8
Moat
73.9
|
-
No YoY
|
27.8%
-1.3
YoY
|
|
|
GMAB
Genmab A/S
|
33.47B
|
Composite
64.6
Moat
74.6
|
-
No YoY
|
28.6%
-2.5
YoY
|
|
RMD
ResMed Inc.
|
33.10B
|
Composite
68.8
Moat
79.3
|
-
No YoY
|
33.4%
+0.6
YoY
|
|
ZTS
Zoetis Inc.
|
32.26B
|
Composite
65.8
Moat
84.8
|
-
No YoY
|
38.0%
+1.4
YoY
|
|
ILMN
Illumina, Inc.
|
32.23B
|
Composite
59.3
Moat
71.4
|
-
No YoY
|
18.6%
+37.6
YoY
|
|
RPRX
Royalty Pharma plc
|
30.09B
|
Composite
66.7
Moat
85.3
|
-
No YoY
|
65.6%
+8.5
YoY
|
|
29.79B
|
Composite
62.2
Moat
61.4
|
82.06
No YoY
|
8.0%
+5.0
YoY
|
|
|
29.77B
|
Composite
57.9
Moat
56.6
|
-
No YoY
|
9.9%
+1.6
YoY
|
|
|
DXCM
DexCom, Inc.
|
29.62B
|
Composite
63.2
Moat
72.7
|
-
No YoY
|
19.6%
+4.7
YoY
|
|
28.12B
|
Composite
62.5
Moat
62.3
|
-
No YoY
|
14.1%
+0.5
YoY
|
|
|
28.08B
|
Composite
51.0
Moat
32.2
|
68.64
-1.2
YoY
|
-62.4%
-27.8
YoY
|
|
|
27.85B
|
Composite
58.6
Moat
64.1
|
-
No YoY
|
19.0%
-0.7
YoY
|
|
|
INSM
Insmed Incorporated
|
25.10B
|
Composite
58.7
Moat
50.5
|
18.35
-6.8
YoY
|
-2.1%
+0.4
YoY
|
|
24.50B
|
Composite
68.8
Moat
69.5
|
-
No YoY
|
18.6%
+2.7
YoY
|
|
|
INCY
Incyte Corporation
|
24.39B
|
Composite
66.9
Moat
82.1
|
-
No YoY
|
29.5%
+28.0
YoY
|
|
23.94B
|
Composite
65.3
Moat
84.0
|
-
No YoY
|
46.9%
-1.0
YoY
|
|
|
VTRS
Viatris Inc.
|
22.83B
|
Composite
57.6
Moat
43.8
|
-
No YoY
|
-18.6%
-18.7
YoY
|
|
22.55B
|
Composite
60.9
Moat
74.1
|
-
No YoY
|
16.5%
-12.4
YoY
|
|
|
BNTX
BioNTech SE
|
21.70B
|
Composite
51.9
Moat
58.1
|
-
No YoY
|
-48.9%
-1.2
YoY
|
|
20.89B
|
Composite
71.4
Moat
74.2
|
3890.0
+3841.4
YoY
|
13.5%
+21.4
YoY
|
|
|
20.41B
|
Composite
42.3
Moat
52.9
|
78.04
+36.0
YoY
|
-44.5%
+15.5
YoY
|
|
|
20.03B
|
Composite
56.4
Moat
61.9
|
33.93
No YoY
|
-6.3%
+31.7
YoY
|
|
|
19.98B
|
Composite
64.0
Moat
72.5
|
-
No YoY
|
13.3%
-3.4
YoY
|
|
|
18.27B
|
Composite
64.5
Moat
67.6
|
-
No YoY
|
21.1%
-0.1
YoY
|
|
|
RVTY
Revvity, Inc.
|
17.31B
|
Composite
58.3
Moat
68.0
|
-
No YoY
|
12.5%
-0.1
YoY
|
|
EXEL
Exelixis, Inc.
|
16.98B
|
Composite
66.1
Moat
82.3
|
-
No YoY
|
37.6%
+9.7
YoY
|
|
HOLX
Hologic, Inc.
|
16.97B
|
Composite
56.0
Moat
58.5
|
-
No YoY
|
17.4%
-4.5
YoY
|
|
ASND
Ascendis Pharma A/S
|
16.87B
|
Composite
72.5
Moat
56.2
|
21.93
+11.7
YoY
|
-18.9%
+57.7
YoY
|
|
16.66B
|
Composite
67.4
Moat
83.4
|
-
No YoY
|
21.6%
-2.6
YoY
|
|
|
16.17B
|
Composite
52.3
Moat
53.5
|
-
No YoY
|
0.6%
-5.0
YoY
|
|
|
15.36B
|
Composite
58.4
Moat
72.3
|
-
No YoY
|
26.2%
+13.7
YoY
|
|
|
ICLR
ICON plc
|
15.34B
|
Composite
51.3
Moat
54.4
|
-
No YoY
|
5.4%
-7.2
YoY
|
|
15.07B
|
Composite
72.4
Moat
65.2
|
-
No YoY
|
-10.1%
-27.7
YoY
|
|
|
14.47B
|
Composite
56.2
Moat
60.7
|
15.81
+0.1
YoY
|
-1.0%
+1.6
YoY
|
|
|
13.99B
|
Composite
64.0
Moat
59.7
|
35.15
No YoY
|
2.3%
+1.2
YoY
|
|
|
TEM
Tempus AI, Inc.
|
13.87B
|
Composite
56.5
Moat
43.7
|
41.54
+13.1
YoY
|
-19.9%
+79.8
YoY
|
|
13.67B
|
Composite
69.4
Moat
75.0
|
-
No YoY
|
12.9%
+1.6
YoY
|
|
|
13.50B
|
Composite
58.8
Moat
77.2
|
-
No YoY
|
17.7%
+1.7
YoY
|
|
|
13.34B
|
Composite
50.3
Moat
40.4
|
-
No YoY
|
-2.7%
-2.9
YoY
|
|
|
GKOS
Glaukos Corporation
|
13.28B
|
Composite
58.8
Moat
50.1
|
226.2
+163.8
YoY
|
-39.3%
-7.4
YoY
|
|
13.03B
|
Composite
52.2
Moat
24.4
|
26.51
-8.3
YoY
|
-102.3%
-54.6
YoY
|
|
|
12.86B
|
Composite
64.3
Moat
58.1
|
-
No YoY
|
5.3%
-0.3
YoY
|
|
|
PEN
Penumbra, Inc.
|
12.58B
|
Composite
62.7
Moat
74.2
|
40.54
No YoY
|
13.5%
+12.7
YoY
|
|
12.44B
|
Composite
63.2
Moat
67.1
|
-
No YoY
|
15.0%
-7.0
YoY
|
|
|
12.14B
|
Composite
51.7
Moat
63.7
|
-
No YoY
|
9.3%
+2.1
YoY
|
|
|
DVA
DaVita Inc.
|
12.04B
|
Composite
52.4
Moat
69.8
|
-
No YoY
|
15.0%
-1.3
YoY
|
|
11.86B
|
Composite
58.9
Moat
73.3
|
-
No YoY
|
16.7%
-1.4
YoY
|
|
|
11.76B
|
Composite
68.4
Moat
77.9
|
-
No YoY
|
33.6%
-20.7
YoY
|
|
|
11.70B
|
Composite
57.4
Moat
68.2
|
-
No YoY
|
13.5%
-1.7
YoY
|
|
|
11.52B
|
Composite
55.4
Moat
71.3
|
-
No YoY
|
11.5%
+0.8
YoY
|
|
|
TECH
Bio-Techne Corp
|
11.41B
|
Composite
72.4
Moat
78.1
|
-
No YoY
|
20.7%
+12.3
YoY
|
|
11.25B
|
Composite
59.4
Moat
47.2
|
43.71
+13.6
YoY
|
-8.9%
-3.4
YoY
|
|
|
RGEN
Repligen Corporation
|
11.09B
|
Composite
56.6
Moat
53.0
|
-
No YoY
|
7.5%
+13.0
YoY
|
|
10.91B
|
Composite
32.8
Moat
62.5
|
185.2
No YoY
|
1.7%
-2.5
YoY
|
|
|
10.85B
|
Composite
66.2
Moat
77.5
|
-
No YoY
|
12.7%
-4.3
YoY
|
|
|
10.56B
|
Composite
54.1
Moat
68.9
|
-
No YoY
|
8.4%
0.0
YoY
|
|
|
AVTR
Avantor, Inc.
|
10.48B
|
Composite
47.4
Moat
47.5
|
-
No YoY
|
-3.8%
-19.8
YoY
|
|
QGEN
Qiagen N.V.
|
10.39B
|
Composite
58.9
Moat
71.0
|
-
No YoY
|
22.3%
+17.4
YoY
|
|
10.26B
|
Composite
53.4
Moat
68.2
|
-
No YoY
|
1.8%
-8.7
YoY
|
|
|
PODD
Insulet Corporation
|
10.16B
|
Composite
65.3
Moat
74.2
|
139.2
No YoY
|
17.5%
+2.6
YoY
|
|
PCVX
Vaxcyte, Inc.
|
10.11B
|
Composite
51.7
Moat
42.5
|
28.57
-17.7
YoY
|
-
No YoY
|
|
10.01B
|
Composite
61.3
Moat
66.6
|
38.52
+2.0
YoY
|
-
No YoY
|
|
|
9.88B
|
Composite
57.0
Moat
67.9
|
-
No YoY
|
1.8%
-8.7
YoY
|
|
|
9.86B
|
Composite
60.8
Moat
26.3
|
53.64
+7.7
YoY
|
-273.5%
-237.1
YoY
|
|
|
NUVL
Nuvalent, Inc.
|
9.82B
|
Composite
60.4
Moat
63.4
|
59.82
-12.7
YoY
|
-
No YoY
|
|
HSIC
Henry Schein, Inc.
|
9.51B
|
Composite
56.2
Moat
71.7
|
-
No YoY
|
5.0%
+0.0
YoY
|
|
OSCR
Oscar Health, Inc.
|
9.51B
|
Composite
58.7
Moat
37.5
|
112.9
No YoY
|
-3.4%
-4.0
YoY
|
|
MASI
Masimo Corporation
|
9.42B
|
Composite
65.4
Moat
65.1
|
-
No YoY
|
20.3%
+15.8
YoY
|
|
GMED
Globus Medical, Inc.
|
9.41B
|
Composite
63.1
Moat
73.9
|
-
No YoY
|
16.3%
+9.7
YoY
|
|
BRKR
Bruker Corporation
|
9.34B
|
Composite
57.6
Moat
55.1
|
-
No YoY
|
2.0%
-5.5
YoY
|
|
9.28B
|
Composite
58.3
Moat
55.0
|
62.27
+37.9
YoY
|
-31.3%
-28.5
YoY
|
|
|
IBRX
ImmunityBio, Inc.
|
9.15B
|
Composite
47.8
Moat
58.5
|
9.56
+5.0
YoY
|
-2.3%
+21.1
YoY
|
|
ATR
AptarGroup, Inc.
|
9.03B
|
Composite
58.2
Moat
64.5
|
-
No YoY
|
13.3%
-0.6
YoY
|
|
8.92B
|
Composite
70.9
Moat
79.3
|
71.91
+26.7
YoY
|
41.4%
+18.8
YoY
|
|
|
8.87B
|
Composite
68.4
Moat
66.4
|
68.77
-23.3
YoY
|
20.0%
+7.3
YoY
|
|
|
8.82B
|
Composite
58.5
Moat
30.2
|
32.64
-37.9
YoY
|
-67.1%
+259.0
YoY
|
|
|
8.57B
|
Composite
64.6
Moat
83.4
|
-
No YoY
|
24.6%
+11.0
YoY
|
|
|
8.54B
|
Composite
70.2
Moat
57.5
|
58.37
+32.0
YoY
|
-3.4%
-61.6
YoY
|
|
|
8.22B
|
Composite
58.7
Moat
58.9
|
17.65
-13.8
YoY
|
11.9%
+181.1
YoY
|
|
|
7.96B
|
Composite
67.8
Moat
78.3
|
-
No YoY
|
5.9%
-14.4
YoY
|
|
|
PACS
PACS Group, Inc.
|
7.87B
|
Composite
51.6
Moat
52.8
|
-
No YoY
|
5.9%
+2.8
YoY
|
|
7.78B
|
Composite
56.4
Moat
51.0
|
40.35
+6.6
YoY
|
-1.0%
+1.0
YoY
|
|
|
7.75B
|
Composite
46.6
Moat
30.1
|
28.88
-6.9
YoY
|
-23.4%
+28.2
YoY
|
|
|
7.72B
|
Composite
53.3
Moat
57.1
|
306.9
+153.4
YoY
|
-9.5%
+22.4
YoY
|
|
|
ALKS
Alkermes plc
|
7.71B
|
Composite
54.0
Moat
76.4
|
-
No YoY
|
17.2%
-9.8
YoY
|
|
7.57B
|
Composite
42.8
Moat
49.8
|
58.56
+6.8
YoY
|
-36.2%
+34.4
YoY
|
|
|
ABVX
Abivax SA
|
7.50B
|
Composite
46.7
Moat
37.6
|
39.50
+28.3
YoY
|
-
No YoY
|
|
7.46B
|
Composite
47.9
Moat
35.2
|
20.76
-11.9
YoY
|
-7.0%
+22.1
YoY
|
|
|
MTSR
Metsera, Inc.
|
7.43B
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
7.37B
|
Composite
65.3
Moat
65.0
|
17.31
No YoY
|
11.4%
+22.2
YoY
|
|
|
7.15B
|
Composite
57.3
Moat
61.3
|
233.6
No YoY
|
2.2%
-1.2
YoY
|
|
|
6.96B
|
Composite
58.7
Moat
54.4
|
41.49
+12.0
YoY
|
-26.1%
+46.6
YoY
|
|
|
CHE
Chemed Corp
|
6.84B
|
Composite
54.7
Moat
76.1
|
-
No YoY
|
13.4%
-1.7
YoY
|
|
ORKA
ARCA biopharma Inc
|
6.81B
|
Composite
55.5
Moat
55.5
|
45.85
-32.1
YoY
|
-
No YoY
|
|
ACLX
Arcellx, Inc.
|
6.75B
|
Composite
51.6
Moat
35.7
|
25.70
-58.7
YoY
|
-11.4%
-10.1
YoY
|
|
CGON
CG Oncology, Inc.
|
6.74B
|
Composite
54.0
Moat
35.2
|
67.29
-45.8
YoY
|
-47.2%
+53.5
YoY
|
|
6.58B
|
Composite
63.9
Moat
72.5
|
-
No YoY
|
20.2%
-9.6
YoY
|
|
|
6.55B
|
Composite
56.9
Moat
64.2
|
119.6
+64.6
YoY
|
-40.5%
+26.9
YoY
|
|
|
IMVT
Immunovant, Inc.
|
6.31B
|
Composite
49.7
Moat
58.0
|
26.58
+3.8
YoY
|
-
No YoY
|
|
6.27B
|
Composite
54.6
Moat
46.3
|
18.24
-22.5
YoY
|
-13.8%
+11.1
YoY
|
|
|
6.23B
|
Composite
53.1
Moat
24.0
|
18.52
+1.3
YoY
|
-
No YoY
|
|
|
6.21B
|
Composite
57.6
Moat
68.2
|
-
No YoY
|
13.1%
+4.1
YoY
|
|
|
BLTE
Belite Bio, Inc
|
6.21B
|
Composite
61.7
Moat
39.9
|
159.8
+100.2
YoY
|
-
No YoY
|
|
6.12B
|
Composite
69.1
Moat
76.5
|
-
No YoY
|
15.3%
+28.8
YoY
|
|
|
6.12B
|
Composite
53.8
Moat
60.3
|
48.43
+33.3
YoY
|
-4.2%
+21.8
YoY
|
|
|
6.11B
|
Composite
51.8
Moat
60.7
|
148.8
+87.4
YoY
|
-49.9%
No YoY
|
|
|
5.98B
|
Composite
55.0
Moat
52.2
|
-
No YoY
|
5.9%
-0.2
YoY
|
|
|
RDNT
RadNet, Inc.
|
5.98B
|
Composite
57.4
Moat
54.3
|
-
No YoY
|
3.0%
-2.7
YoY
|
|
GRFS
Grifols, S.A.
|
5.80B
|
Composite
38.6
Moat
49.6
|
4879.4
No YoY
|
16.5%
-0.0
YoY
|
|
DOCS
Doximity, Inc.
|
5.79B
|
Composite
62.3
Moat
86.4
|
-
No YoY
|
33.3%
-6.6
YoY
|
|
5.72B
|
Composite
56.3
Moat
51.2
|
14.70
-11.4
YoY
|
-4.0%
+2.9
YoY
|
|
|
5.49B
|
Composite
57.5
Moat
46.1
|
40.88
+24.3
YoY
|
-
No YoY
|
|
|
5.47B
|
Composite
61.5
Moat
76.8
|
127.0
+60.6
YoY
|
50.1%
+87.6
YoY
|
|
|
5.46B
|
Composite
54.9
Moat
65.4
|
-
No YoY
|
11.8%
-4.6
YoY
|
|
|
5.45B
|
Composite
65.0
Moat
76.3
|
-
No YoY
|
22.7%
+9.6
YoY
|
|
|
GRAL
GRAIL, Inc.
|
5.43B
|
Composite
41.5
Moat
31.3
|
36.30
+20.4
YoY
|
-3.8%
+13.6
YoY
|
|
5.43B
|
Composite
54.8
Moat
55.0
|
-
No YoY
|
-8.7%
-21.0
YoY
|
|
|
5.38B
|
Composite
61.7
Moat
70.3
|
-
No YoY
|
15.4%
-0.6
YoY
|
|
|
5.25B
|
Composite
65.6
Moat
67.6
|
56.17
+49.1
YoY
|
5.5%
+26.6
YoY
|
|
|
5.24B
|
Composite
63.4
Moat
47.8
|
56.02
No YoY
|
1.7%
+4.2
YoY
|
|
|
5.23B
|
Composite
53.5
Moat
69.0
|
-
No YoY
|
12.2%
+0.7
YoY
|
|
|
ERAS
Erasca, Inc.
|
5.04B
|
Composite
57.2
Moat
61.2
|
34.71
+2.0
YoY
|
-
No YoY
|
|
LIVN
LivaNova PLC
|
4.96B
|
Composite
63.5
Moat
71.6
|
-
No YoY
|
14.4%
+4.1
YoY
|
|
4.93B
|
Composite
54.1
Moat
60.4
|
44.23
-7.5
YoY
|
-
No YoY
|
|
|
4.86B
|
Composite
53.0
Moat
41.1
|
68.72
-91.3
YoY
|
-13.3%
+46.8
YoY
|
|
|
4.84B
|
Composite
58.0
Moat
35.2
|
37.59
-4.7
YoY
|
-87.4%
-71.1
YoY
|
|
|
4.76B
|
Composite
61.7
Moat
60.0
|
18.73
-5.6
YoY
|
-12.8%
-11.4
YoY
|
|
|
4.74B
|
Composite
50.4
Moat
62.1
|
-
No YoY
|
6.0%
-0.5
YoY
|
|
|
4.57B
|
Composite
60.8
Moat
76.0
|
24.08
No YoY
|
31.1%
+4.1
YoY
|
|
|
4.55B
|
Composite
67.7
Moat
68.2
|
88.50
+38.8
YoY
|
5.2%
+0.5
YoY
|
|
|
4.53B
|
Composite
63.0
Moat
61.7
|
113.6
+20.1
YoY
|
-13.3%
+36.1
YoY
|
|
|
4.53B
|
Composite
56.1
Moat
64.1
|
59.23
+31.2
YoY
|
-20.6%
+70.2
YoY
|
|
|
ICUI
ICU Medical, Inc.
|
4.30B
|
Composite
54.2
Moat
49.0
|
41.14
No YoY
|
1.9%
+0.1
YoY
|
|
4.30B
|
Composite
56.3
Moat
63.4
|
-
No YoY
|
11.9%
-0.2
YoY
|
|
|
INDV
Indivior PLC
|
4.28B
|
Composite
60.5
Moat
66.9
|
86.67
+70.3
YoY
|
21.1%
+17.9
YoY
|
|
PINC
Premier, Inc.
|
4.13B
|
Composite
51.6
Moat
58.7
|
-
No YoY
|
0.1%
-11.0
YoY
|
|
CDNA
CareDx, Inc.
|
4.13B
|
Composite
58.7
Moat
61.4
|
153.6
+14.3
YoY
|
-8.1%
-20.3
YoY
|
|
4.11B
|
Composite
51.8
Moat
45.2
|
28.26
-9.4
YoY
|
-19.7%
+17.5
YoY
|
|
|
4.04B
|
Composite
54.2
Moat
59.6
|
-
No YoY
|
8.0%
+49.3
YoY
|
|
|
LQDA
Liquidia Corporation
|
3.97B
|
Composite
79.2
Moat
54.0
|
64.12
+41.5
YoY
|
-32.5%
-23.8
YoY
|
|
3.85B
|
Composite
65.4
Moat
82.6
|
-
No YoY
|
43.8%
+4.1
YoY
|
|
|
3.85B
|
Composite
58.6
Moat
56.4
|
48.79
-20.4
YoY
|
-2.9%
+8.0
YoY
|
|
|
3.80B
|
Composite
34.3
Moat
12.1
|
17.90
-21.1
YoY
|
-219.8%
-136.9
YoY
|
|
|
3.79B
|
Composite
49.2
Moat
38.0
|
23.60
-17.9
YoY
|
-49.7%
-36.1
YoY
|
|
|
3.71B
|
Composite
49.0
Moat
62.6
|
-
No YoY
|
16.8%
+2.2
YoY
|
|
|
3.70B
|
Composite
54.5
Moat
45.6
|
30.84
+18.2
YoY
|
-3.6%
-13.8
YoY
|
|
|
3.67B
|
Composite
65.0
Moat
75.0
|
43.86
-5.9
YoY
|
9.8%
-14.3
YoY
|
|
|
OGN
Organon & Co.
|
3.64B
|
Composite
30.4
Moat
40.2
|
-
No YoY
|
19.7%
-3.5
YoY
|
|
3.64B
|
Composite
60.9
Moat
47.8
|
11.78
+0.8
YoY
|
-1.5%
+0.9
YoY
|
|
|
3.63B
|
Composite
60.1
Moat
60.4
|
29.65
+6.1
YoY
|
-1.8%
+1.7
YoY
|
|
|
3.62B
|
Composite
56.0
Moat
50.6
|
78.97
+27.6
YoY
|
-
No YoY
|
|
|
IRON
Disc Medicine, Inc.
|
3.50B
|
Composite
58.8
Moat
47.7
|
52.63
-10.0
YoY
|
-
No YoY
|
|
3.44B
|
Composite
47.7
Moat
50.5
|
-
No YoY
|
11.7%
-4.8
YoY
|
|
|
3.42B
|
Composite
46.3
Moat
39.7
|
30.39
-93.0
YoY
|
-5203.4%
No YoY
|
|
|
3.38B
|
Composite
68.3
Moat
59.5
|
402.2
+360.0
YoY
|
-15.7%
+50.2
YoY
|
|
|
3.37B
|
Composite
60.1
Moat
46.2
|
33.05
+6.7
YoY
|
-
No YoY
|
|
|
3.27B
|
Composite
60.0
Moat
73.1
|
-
No YoY
|
8.5%
+1.5
YoY
|
|
|
CELC
Celcuity Inc.
|
3.27B
|
Composite
43.8
Moat
48.4
|
34.56
+0.8
YoY
|
-
No YoY
|
|
3.24B
|
Composite
50.2
Moat
43.6
|
37.97
+0.9
YoY
|
-5.1%
+985.1
YoY
|
|
|
3.23B
|
Composite
72.0
Moat
54.8
|
471.4
+447.0
YoY
|
-3.2%
+62.1
YoY
|
|
|
3.22B
|
Composite
50.8
Moat
61.6
|
25.24
-3.5
YoY
|
-59.5%
-56.4
YoY
|
|
|
3.19B
|
Composite
62.1
Moat
56.4
|
65.64
+50.8
YoY
|
3.7%
-7.0
YoY
|
|
|
WRBY
Warby Parker Inc.
|
3.17B
|
Composite
57.1
Moat
54.2
|
96.17
No YoY
|
-0.6%
+3.3
YoY
|
|
3.12B
|
Composite
59.5
Moat
60.2
|
-
No YoY
|
1.6%
+0.6
YoY
|
|
|
3.06B
|
Composite
62.6
Moat
69.7
|
363.7
+311.0
YoY
|
17.9%
+9.4
YoY
|
|
|
3.06B
|
Composite
55.6
Moat
68.1
|
9.30
No YoY
|
17.7%
+1.6
YoY
|
|
|
3.04B
|
Composite
46.8
Moat
61.0
|
-
No YoY
|
11.8%
+0.6
YoY
|
|
|
3.02B
|
Composite
55.3
Moat
58.0
|
107.9
+75.1
YoY
|
-72.8%
-26.1
YoY
|
|
|
AXGN
AxoGen, Inc.
|
2.99B
|
Composite
60.5
Moat
65.8
|
65.13
+28.7
YoY
|
-3.5%
-1.7
YoY
|
|
ATRC
AtriCure, Inc.
|
2.98B
|
Composite
60.2
Moat
69.4
|
65.64
-38.1
YoY
|
-1.8%
+6.8
YoY
|
|
2.97B
|
Composite
65.7
Moat
65.2
|
32.04
-79.1
YoY
|
-7.7%
+11.8
YoY
|
|
|
2.89B
|
Composite
57.1
Moat
55.4
|
4.76
-27.5
YoY
|
10.5%
+3.6
YoY
|
|
|
ZLAB
Zai Lab Limited
|
2.86B
|
Composite
54.4
Moat
58.0
|
54.88
+11.3
YoY
|
-49.9%
+20.8
YoY
|
|
ADMA
ADMA Biologics Inc
|
2.82B
|
Composite
63.5
Moat
76.6
|
17.45
+12.0
YoY
|
37.5%
+4.9
YoY
|
|
VCEL
Vericel Corporation
|
2.80B
|
Composite
68.9
Moat
74.6
|
-
No YoY
|
4.0%
+2.1
YoY
|
|
2.78B
|
Composite
61.3
Moat
66.7
|
23.24
+4.8
YoY
|
8.5%
+25.1
YoY
|
|
|
2.76B
|
Composite
68.2
Moat
70.7
|
50.61
-31.0
YoY
|
4.9%
No YoY
|
|
|
2.69B
|
Composite
56.5
Moat
57.6
|
-
No YoY
|
5.0%
+10.1
YoY
|
|
|
XNCR
Xencor, Inc.
|
2.68B
|
Composite
57.2
Moat
61.3
|
48.65
+19.1
YoY
|
-1.4%
+0.2
YoY
|
|
2.64B
|
Composite
53.7
Moat
50.5
|
253.8
+225.6
YoY
|
-6.5%
-0.1
YoY
|
|
|
2.63B
|
Composite
43.6
Moat
53.8
|
43.30
+13.9
YoY
|
-2.7%
+3.8
YoY
|
|
|
2.63B
|
Composite
52.9
Moat
53.1
|
24.42
-44.6
YoY
|
-1.6%
-0.3
YoY
|
|
|
2.61B
|
Composite
47.5
Moat
36.9
|
22.13
-1.7
YoY
|
-
No YoY
|
|
|
2.57B
|
Composite
47.5
Moat
20.2
|
21.56
+2.0
YoY
|
-4.4%
-1.1
YoY
|
|
|
NEOG
Neogen Corporation
|
2.57B
|
Composite
53.1
Moat
54.5
|
-
No YoY
|
-2.5%
-1.3
YoY
|
|
PGNY
Progyny, Inc.
|
2.57B
|
Composite
59.9
Moat
71.4
|
-
No YoY
|
6.6%
+0.8
YoY
|
|
2.53B
|
Composite
66.9
Moat
49.2
|
27.82
-64.7
YoY
|
-1.6%
No YoY
|
|
|
2.47B
|
Composite
64.8
Moat
47.9
|
56.09
-1.4
YoY
|
-
No YoY
|
|
|
2.44B
|
Composite
55.8
Moat
64.9
|
-
No YoY
|
10.9%
+14.3
YoY
|
|
|
2.44B
|
Composite
50.2
Moat
62.0
|
142.7
No YoY
|
5.1%
-1.7
YoY
|
|
|
PHVS
Pharvaris N.V.
|
2.41B
|
Composite
60.4
Moat
39.5
|
25.53
-2.5
YoY
|
-
No YoY
|
|
2.35B
|
Composite
61.9
Moat
64.8
|
-
No YoY
|
15.3%
-0.7
YoY
|
|
|
2.35B
|
Composite
49.6
Moat
27.5
|
29.50
-25.7
YoY
|
-186.0%
-158.2
YoY
|
|
|
2.32B
|
Composite
56.2
Moat
68.4
|
-
No YoY
|
9.7%
+0.8
YoY
|
|
|
SEPN
Septerna, Inc.
|
2.28B
|
Composite
70.2
Moat
59.6
|
62.41
+35.0
YoY
|
-1.5%
+73.7
YoY
|
|
2.27B
|
Composite
55.1
Moat
43.6
|
51.66
-11.5
YoY
|
-10.0%
-6.2
YoY
|
|
|
SDGR
Schrodinger, Inc.
|
2.24B
|
Composite
43.7
Moat
42.9
|
26.85
-13.8
YoY
|
-65.2%
-64.2
YoY
|
|
2.22B
|
Composite
60.3
Moat
58.5
|
51.02
-30.7
YoY
|
-80.8%
-79.1
YoY
|
|
|
IMNM
Immunome, Inc.
|
2.21B
|
Composite
52.2
Moat
35.5
|
41.07
+17.5
YoY
|
-32.3%
+1.5
YoY
|
|
2.21B
|
Composite
70.1
Moat
77.4
|
125.7
+66.9
YoY
|
37.1%
+39.0
YoY
|
|
|
PRGO
Perrigo Company plc
|
2.20B
|
Composite
56.8
Moat
43.6
|
-
No YoY
|
-26.4%
-29.0
YoY
|
|
2.19B
|
Composite
50.3
Moat
41.5
|
23.99
+4.1
YoY
|
-8.7%
-0.5
YoY
|
|
|
BHVN
Biohaven Ltd.
|
2.19B
|
Composite
51.5
Moat
17.5
|
6.28
-3.7
YoY
|
-
No YoY
|
|
2.18B
|
Composite
52.9
Moat
49.9
|
2551.2
+2471.5
YoY
|
-15.9%
-2.0
YoY
|
|
|
2.15B
|
Composite
53.9
Moat
42.0
|
35.57
-21.5
YoY
|
-
No YoY
|
|
|
2.15B
|
Composite
42.6
Moat
39.8
|
67.13
No YoY
|
0.4%
-1.1
YoY
|
|
|
2.12B
|
Composite
66.7
Moat
57.2
|
-
No YoY
|
-32.0%
-26.0
YoY
|
|
|
ZYME
Zymeworks Inc.
|
2.10B
|
Composite
53.4
Moat
62.8
|
83.19
+58.6
YoY
|
-87.3%
-85.5
YoY
|
|
2.09B
|
Composite
63.2
Moat
44.8
|
14.30
-10.0
YoY
|
-7.2%
+2.0
YoY
|
|
|
2.05B
|
Composite
47.3
Moat
38.1
|
11.51
-18.7
YoY
|
-
No YoY
|
|
|
2.05B
|
Composite
43.1
Moat
48.9
|
-
No YoY
|
6.2%
+1.0
YoY
|
|
|
2.04B
|
Composite
53.0
Moat
39.2
|
53.67
+19.9
YoY
|
-
No YoY
|
|
|
2.04B
|
Composite
57.3
Moat
76.1
|
-
No YoY
|
28.4%
-1.2
YoY
|
|
|
2.00B
|
Composite
51.4
Moat
60.0
|
17.82
-0.7
YoY
|
-18.5%
+11.6
YoY
|
|
|
1.98B
|
Composite
58.5
Moat
74.0
|
74.01
+25.0
YoY
|
39.0%
+39.5
YoY
|
|
|
1.96B
|
Composite
56.3
Moat
26.7
|
29.92
+20.9
YoY
|
-157.5%
+175.9
YoY
|
|
|
1.95B
|
Composite
66.3
Moat
53.2
|
45.21
No YoY
|
-1.2%
+89.8
YoY
|
|
|
GLPG
Galapagos NV
|
1.95B
|
Composite
55.6
Moat
79.1
|
139.7
+22.8
YoY
|
26.5%
+94.9
YoY
|
|
VCYT
Veracyte, Inc.
|
1.95B
|
Composite
60.5
Moat
70.0
|
67.23
No YoY
|
11.2%
+7.5
YoY
|
|
1.94B
|
Composite
69.8
Moat
79.6
|
-
No YoY
|
24.0%
-2.7
YoY
|
|
|
ASTH
Astrana Health Inc.
|
1.92B
|
Composite
47.9
Moat
40.2
|
-
No YoY
|
2.5%
-1.9
YoY
|
|
1.91B
|
Composite
57.4
Moat
59.9
|
54.88
-24.1
YoY
|
-31.8%
-43.3
YoY
|
|
|
1.90B
|
Composite
40.2
Moat
26.9
|
32.35
-50.7
YoY
|
-7.8%
-3.0
YoY
|
|
|
1.89B
|
Composite
57.8
Moat
58.3
|
42.42
-46.2
YoY
|
-17.3%
-11.3
YoY
|
|
|
XRAY
DENTSPLY SIRONA Inc.
|
1.87B
|
Composite
50.0
Moat
42.4
|
-
No YoY
|
-11.5%
+11.7
YoY
|
|
1.86B
|
Composite
45.5
Moat
61.2
|
59.45
+50.8
YoY
|
-3.1%
+4.5
YoY
|
|
|
1.85B
|
Composite
65.7
Moat
73.0
|
-
No YoY
|
5.6%
+1.1
YoY
|
|
|
MESO
Mesoblast Limited
|
1.85B
|
Composite
55.7
Moat
59.8
|
38.71
+23.2
YoY
|
-42.6%
-39.0
YoY
|
|
1.85B
|
Composite
65.7
Moat
79.8
|
-
No YoY
|
27.2%
+3.4
YoY
|
|
|
1.84B
|
Composite
63.0
Moat
74.7
|
36.65
+32.6
YoY
|
34.4%
No YoY
|
|
|
1.84B
|
Composite
51.6
Moat
25.8
|
23.90
-11.3
YoY
|
-38.3%
-5.5
YoY
|
|
|
CERT
Certara, Inc.
|
1.84B
|
Composite
50.2
Moat
67.5
|
-
No YoY
|
5.0%
+5.5
YoY
|
|
1.79B
|
Composite
58.4
Moat
33.9
|
33.29
+13.6
YoY
|
-56.2%
-38.0
YoY
|
|
|
NVAX
Novavax, Inc.
|
1.78B
|
Composite
45.5
Moat
70.9
|
36.06
-90.9
YoY
|
40.3%
+76.8
YoY
|
|
1.76B
|
Composite
58.9
Moat
49.2
|
27.49
-0.0
YoY
|
-8.7%
+2.9
YoY
|
|
|
1.75B
|
Composite
50.9
Moat
45.7
|
41.51
+22.9
YoY
|
-
No YoY
|
|
|
ABSI
Absci Corporation
|
1.75B
|
Composite
53.6
Moat
31.7
|
18.63
-0.0
YoY
|
-43.0%
-19.0
YoY
|
|
1.74B
|
Composite
58.6
Moat
67.7
|
29.97
+0.2
YoY
|
-11.2%
-8.4
YoY
|
|
|
ALVO
Alvotech
|
1.73B
|
Composite
41.9
Moat
55.3
|
41.20
+38.6
YoY
|
13.3%
-0.9
YoY
|
|
OMCL
Omnicell, Inc.
|
1.72B
|
Composite
57.6
Moat
56.0
|
-
No YoY
|
0.4%
+0.4
YoY
|
|
AZTA
Azenta, Inc.
|
1.72B
|
Composite
50.4
Moat
61.1
|
40.43
No YoY
|
-4.5%
+4.4
YoY
|
|
PSNL
Personalis, Inc.
|
1.71B
|
Composite
42.8
Moat
29.4
|
38.42
-10.8
YoY
|
-1.3%
+79.4
YoY
|
|
1.70B
|
Composite
52.8
Moat
48.7
|
142.2
+116.7
YoY
|
-88.5%
+2.2
YoY
|
|
|
1.70B
|
Composite
62.1
Moat
29.9
|
30.35
+25.6
YoY
|
-42.0%
-38.6
YoY
|
|
|
1.67B
|
Composite
72.5
Moat
56.4
|
28.52
-13.9
YoY
|
-3.4%
+0.5
YoY
|
|
|
1.64B
|
Composite
54.0
Moat
64.7
|
178.5
No YoY
|
3.0%
-0.1
YoY
|
|
|
1.61B
|
Composite
64.8
Moat
47.0
|
36.62
No YoY
|
-1.1%
+5.6
YoY
|
|
|
PGEN
Precigen, Inc.
|
1.60B
|
Composite
61.8
Moat
31.1
|
13.37
-3.9
YoY
|
-11.4%
+23.0
YoY
|
|
TDOC
Teladoc Health, Inc.
|
1.60B
|
Composite
50.1
Moat
47.9
|
-
No YoY
|
-10.4%
+29.3
YoY
|
|
1.60B
|
Composite
59.1
Moat
64.5
|
968.1
+869.9
YoY
|
-11.3%
+11.4
YoY
|
|
|
1.59B
|
Composite
50.4
Moat
47.5
|
13.68
-7.0
YoY
|
-6.5%
+2.7
YoY
|
|
|
1.57B
|
Composite
39.7
Moat
36.8
|
114.4
+35.7
YoY
|
-3.5%
-0.6
YoY
|
|
|
1.57B
|
Composite
51.4
Moat
67.0
|
17.51
-0.2
YoY
|
-79.5%
+16.2
YoY
|
|
|
NVCR
NovoCure Limited
|
1.55B
|
Composite
54.6
Moat
59.9
|
109.6
-327.3
YoY
|
-23.5%
+4.7
YoY
|
|
1.55B
|
Composite
62.0
Moat
69.8
|
18.55
No YoY
|
12.6%
+12.5
YoY
|
|
|
1.54B
|
Composite
50.2
Moat
42.7
|
64.64
-43.5
YoY
|
0.4%
+4.1
YoY
|
|
|
CNMD
CONMED Corporation
|
1.53B
|
Composite
58.5
Moat
65.3
|
-
No YoY
|
7.5%
-7.9
YoY
|
|
NBTX
Nanobiotix S.A.
|
1.53B
|
Composite
51.6
Moat
65.0
|
18.94
-11.6
YoY
|
-36.5%
-42.4
YoY
|
|
QURE
uniQure N.V.
|
1.52B
|
Composite
54.4
Moat
39.6
|
41.98
+17.8
YoY
|
-11.5%
-4.7
YoY
|
|
GLTO
Galecto, Inc.
|
1.49B
|
Composite
51.8
Moat
39.4
|
9.13
-1.6
YoY
|
-
No YoY
|
|
1.48B
|
Composite
51.9
Moat
60.9
|
-
No YoY
|
11.1%
+1.7
YoY
|
|
|
NUVB
Nuvation Bio Inc.
|
1.47B
|
Composite
61.3
Moat
48.4
|
36.62
-9.6
YoY
|
-3.4%
+71.9
YoY
|
|
1.45B
|
Composite
52.9
Moat
48.4
|
32.29
-26.4
YoY
|
-
No YoY
|
|
|
1.45B
|
Composite
57.8
Moat
62.4
|
-
No YoY
|
2.6%
+13.1
YoY
|
|
|
1.45B
|
Composite
56.7
Moat
58.3
|
78.10
-12.8
YoY
|
-
No YoY
|
|
|
1.45B
|
Composite
63.1
Moat
48.3
|
67.29
+10.8
YoY
|
-
No YoY
|
|
|
1.45B
|
Composite
55.8
Moat
49.7
|
43.17
+8.2
YoY
|
-5.2%
-2.5
YoY
|
|
|
1.44B
|
Composite
58.1
Moat
45.7
|
17.31
-11.0
YoY
|
-4.6%
No YoY
|
|
|
1.41B
|
Composite
59.7
Moat
37.3
|
41.22
+20.7
YoY
|
-11.3%
-0.3
YoY
|
|
|
1.40B
|
Composite
44.4
Moat
32.8
|
-
No YoY
|
-2.0%
+1.4
YoY
|
|
|
ANAB
AnaptysBio, Inc.
|
1.39B
|
Composite
55.8
Moat
62.7
|
25.30
-13.5
YoY
|
96.7%
+24.2
YoY
|
|
1.37B
|
Composite
52.1
Moat
58.6
|
25.19
-108.1
YoY
|
4.4%
-7.2
YoY
|
|
|
INVA
Innoviva, Inc.
|
1.36B
|
Composite
61.4
Moat
81.6
|
-
No YoY
|
39.8%
-6.7
YoY
|
|
1.36B
|
Composite
55.3
Moat
51.4
|
55.33
+41.0
YoY
|
-
No YoY
|
|
|
1.34B
|
Composite
63.1
Moat
68.6
|
-
No YoY
|
12.8%
+4.3
YoY
|
|
|
1.33B
|
Composite
60.2
Moat
46.0
|
241.4
+122.9
YoY
|
-11.9%
+53.2
YoY
|
|
|
1.28B
|
Composite
41.4
Moat
42.5
|
24.81
-3.4
YoY
|
-19.4%
+2.0
YoY
|
|
|
GHRS
GH Research PLC
|
1.28B
|
Composite
58.8
Moat
50.3
|
77.34
+35.0
YoY
|
-
No YoY
|
|
1.28B
|
Composite
50.2
Moat
54.9
|
3.42
No YoY
|
5.5%
-0.0
YoY
|
|
|
NKTR
Nektar Therapeutics
|
1.27B
|
Composite
58.7
Moat
56.7
|
14.14
-3.3
YoY
|
-2.5%
-1.5
YoY
|
|
1.27B
|
Composite
58.9
Moat
36.9
|
32.89
-3.3
YoY
|
-
No YoY
|
|
|
1.26B
|
Composite
56.8
Moat
51.0
|
65.74
No YoY
|
-38.3%
-34.3
YoY
|
|
|
MNKD
MannKind Corporation
|
1.25B
|
Composite
55.5
Moat
72.3
|
25.41
-14.3
YoY
|
11.1%
-14.3
YoY
|
|
1.24B
|
Composite
35.8
Moat
17.2
|
11.48
+2.1
YoY
|
-103.9%
+1553.4
YoY
|
|
|
NUTX
Nutex Health Inc.
|
1.24B
|
Composite
63.5
Moat
74.2
|
-
No YoY
|
31.5%
+4.3
YoY
|
|
SVRA
Savara, Inc.
|
1.23B
|
Composite
52.0
Moat
43.1
|
27.99
+1.5
YoY
|
-
No YoY
|
|
OMER
Omeros Corporation
|
1.22B
|
Composite
59.9
Moat
37.2
|
17.76
+10.5
YoY
|
-
No YoY
|
|
1.22B
|
Composite
49.8
Moat
44.3
|
33.43
No YoY
|
0.3%
+3.8
YoY
|
|
|
1.22B
|
Composite
52.8
Moat
65.4
|
38.28
+27.2
YoY
|
-
No YoY
|
|
|
URGN
UroGen Pharma Ltd.
|
1.21B
|
Composite
56.3
Moat
50.3
|
8.90
-20.5
YoY
|
-1.1%
-0.1
YoY
|
|
1.21B
|
Composite
58.8
Moat
75.7
|
-
No YoY
|
19.5%
-8.6
YoY
|
|
|
1.20B
|
Composite
59.0
Moat
73.9
|
-
No YoY
|
11.0%
+2.7
YoY
|
|
|
1.19B
|
Composite
33.0
Moat
49.0
|
11.42
-5.2
YoY
|
-
No YoY
|
|
|
1.19B
|
Composite
48.2
Moat
22.2
|
16.40
-9.7
YoY
|
-162.9%
-161.5
YoY
|
|
|
1.19B
|
Composite
52.5
Moat
53.9
|
70.19
+29.8
YoY
|
-33.7%
+9.3
YoY
|
|
|
1.18B
|
Composite
51.8
Moat
48.5
|
361.3
+184.8
YoY
|
-18.4%
-7.9
YoY
|
|
|
AVNS
Avanos Medical, Inc.
|
1.17B
|
Composite
51.9
Moat
54.8
|
-
No YoY
|
-8.8%
+48.8
YoY
|
|
1.16B
|
Composite
36.0
Moat
14.2
|
0.16
-29.1
YoY
|
-1.5%
+9.8
YoY
|
|
|
1.15B
|
Composite
49.7
Moat
64.5
|
37.31
+3.5
YoY
|
-10.8%
+11.5
YoY
|
|
|
IRMD
iRadimed Corporation
|
1.10B
|
Composite
70.2
Moat
83.1
|
-
No YoY
|
31.2%
+1.2
YoY
|
|
SIBN
SI-BONE, Inc.
|
1.09B
|
Composite
56.5
Moat
63.1
|
2628.0
+2483.1
YoY
|
-11.1%
+10.0
YoY
|
|
1.08B
|
Composite
62.7
Moat
46.8
|
141.0
-139.7
YoY
|
-15.8%
-6.4
YoY
|
|
|
VSTM
Verastem, Inc.
|
1.06B
|
Composite
56.9
Moat
35.6
|
18.66
+8.5
YoY
|
-5.5%
+6.0
YoY
|
|
CVAC
CureVac N.V.
|
1.05B
|
Composite
62.7
Moat
72.7
|
18.15
-2.8
YoY
|
33.2%
+38.3
YoY
|
|
1.04B
|
Composite
58.7
Moat
46.8
|
-
No YoY
|
-30.2%
-31.9
YoY
|
|
|
CBLL
CeriBell, Inc.
|
1.03B
|
Composite
50.2
Moat
53.1
|
46.83
-19.7
YoY
|
-65.6%
-4.9
YoY
|
|
HROW
Harrow, Inc.
|
1.01B
|
Composite
50.9
Moat
61.4
|
25.54
No YoY
|
11.2%
+6.8
YoY
|
|
1.00B
|
Composite
51.4
Moat
45.0
|
19.93
+1.8
YoY
|
-
No YoY
|
|
|
1.00B
|
Composite
49.7
Moat
68.7
|
518.5
+444.0
YoY
|
-12.4%
-15.1
YoY
|
|
|
987.33M
|
Composite
56.4
Moat
35.9
|
-
No YoY
|
-57.4%
No YoY
|
|
|
AORT
Artivion, Inc.
|
985.40M
|
Composite
60.2
Moat
68.3
|
91.64
-163.7
YoY
|
7.6%
-2.4
YoY
|
|
981.28M
|
Composite
49.3
Moat
41.6
|
24.12
-22.0
YoY
|
-
No YoY
|
|
|
AHCO
AdaptHealth Corp.
|
979.22M
|
Composite
50.5
Moat
59.0
|
-
No YoY
|
2.8%
-5.3
YoY
|
|
914.22M
|
Composite
58.9
Moat
55.2
|
30.44
+3.2
YoY
|
-
No YoY
|
|
|
901.76M
|
Composite
60.3
Moat
61.7
|
198.5
+134.8
YoY
|
-43.8%
-42.8
YoY
|
|
|
896.79M
|
Composite
55.2
Moat
28.5
|
18.15
-4.6
YoY
|
-
No YoY
|
|
|
895.70M
|
Composite
42.2
Moat
32.3
|
26.41
+12.9
YoY
|
-31.5%
-20.8
YoY
|
|
|
886.60M
|
Composite
55.7
Moat
46.5
|
20.76
-3.8
YoY
|
-
No YoY
|
|
|
884.20M
|
Composite
63.5
Moat
69.6
|
91.91
+46.4
YoY
|
-3.4%
+69.6
YoY
|
|
|
TALK
Talkspace, Inc.
|
874.42M
|
Composite
57.4
Moat
50.2
|
90.70
+63.5
YoY
|
1.4%
+3.8
YoY
|
|
IMTX
Immatics N.V.
|
869.35M
|
Composite
55.2
Moat
53.5
|
31.89
-14.0
YoY
|
-3.8%
+21.0
YoY
|
|
PHAR
Pharming Group N.V.
|
869.24M
|
Composite
58.9
Moat
74.2
|
1122.4
+974.4
YoY
|
6.9%
+9.8
YoY
|
|
864.40M
|
Composite
65.4
Moat
51.5
|
17.07
+5.2
YoY
|
-1.3%
+3.6
YoY
|
|
|
858.87M
|
Composite
57.1
Moat
49.1
|
15.37
-10.1
YoY
|
-1.6%
+12.8
YoY
|
|
|
BBNX
Beta Bionics, Inc.
|
853.56M
|
Composite
54.0
Moat
45.2
|
51.63
+25.9
YoY
|
-71.5%
-2.0
YoY
|
|
HSTM
HealthStream, Inc.
|
844.70M
|
Composite
58.5
Moat
74.3
|
-
No YoY
|
6.7%
-0.6
YoY
|
|
829.27M
|
Composite
52.4
Moat
67.9
|
150.5
+120.0
YoY
|
-16.6%
+0.5
YoY
|
|
|
PRME
Prime Medicine, Inc.
|
827.26M
|
Composite
50.7
Moat
34.8
|
13.12
-5.5
YoY
|
-45.0%
+22.9
YoY
|
|
822.04M
|
Composite
46.5
Moat
49.8
|
153.8
+80.4
YoY
|
14.9%
-1.4
YoY
|
|
|
ANNX
Annexon, Inc.
|
796.23M
|
Composite
56.0
Moat
43.2
|
15.35
-16.4
YoY
|
-
No YoY
|
|
792.02M
|
Composite
52.8
Moat
52.9
|
17.02
+1.0
YoY
|
-98.2%
-91.9
YoY
|
|
|
788.20M
|
Composite
62.0
Moat
73.1
|
-
No YoY
|
23.0%
-3.9
YoY
|
|
|
PHR
Phreesia, Inc.
|
783.34M
|
Composite
58.6
Moat
56.0
|
32.44
+8.9
YoY
|
-1.4%
+12.5
YoY
|
|
ALMS
Alumis Inc.
|
780.49M
|
Composite
48.1
Moat
28.2
|
10.02
-3.5
YoY
|
-18.9%
No YoY
|
|
776.30M
|
Composite
60.5
Moat
55.5
|
-
No YoY
|
-3.3%
-7.2
YoY
|
|
|
INMD
InMode Ltd.
|
766.22M
|
Composite
63.1
Moat
72.3
|
-
No YoY
|
23.1%
-5.4
YoY
|
|
762.47M
|
Composite
47.1
Moat
50.3
|
669.7
+335.0
YoY
|
-20.0%
-9.8
YoY
|
|
|
760.27M
|
Composite
55.1
Moat
47.8
|
29.65
+8.6
YoY
|
-1.9%
+0.6
YoY
|
|
|
740.70M
|
Composite
66.1
Moat
75.6
|
119.0
+109.5
YoY
|
42.6%
+29.1
YoY
|
|
|
734.15M
|
Composite
48.7
Moat
39.9
|
-
No YoY
|
-33.7%
+36.8
YoY
|
|
|
OABI
OmniAb, Inc.
|
733.68M
|
Composite
63.3
Moat
54.5
|
17.78
-0.2
YoY
|
-3.7%
-0.9
YoY
|
|
732.52M
|
Composite
58.3
Moat
18.1
|
23.71
+5.6
YoY
|
-
No YoY
|
|
|
727.85M
|
Composite
58.3
Moat
58.2
|
25.80
-7.1
YoY
|
-3.6%
No YoY
|
|
|
BVS
Bioventus Inc.
|
726.51M
|
Composite
62.1
Moat
68.8
|
26.76
No YoY
|
9.5%
+12.2
YoY
|
|
725.40M
|
Composite
57.0
Moat
71.0
|
-
No YoY
|
33.3%
+6.8
YoY
|
|
|
ARDX
Ardelyx, Inc.
|
723.95M
|
Composite
60.3
Moat
61.1
|
74.77
+7.8
YoY
|
-10.1%
-1.7
YoY
|
|
723.13M
|
Composite
55.3
Moat
53.4
|
27.69
+5.0
YoY
|
-2.7%
+9.7
YoY
|
|
|
720.09M
|
Composite
47.2
Moat
36.3
|
176.3
+134.0
YoY
|
-1.0%
+2.8
YoY
|
|
|
718.10M
|
Composite
51.3
Moat
60.7
|
48.49
+5.3
YoY
|
-
No YoY
|
|
|
709.48M
|
Composite
62.6
Moat
31.9
|
11.55
+3.3
YoY
|
-
No YoY
|
|
|
706.60M
|
Composite
54.8
Moat
42.3
|
14.42
-3.4
YoY
|
-13.2%
-7.8
YoY
|
|
|
EHAB
Enhabit, Inc.
|
706.56M
|
Composite
56.2
Moat
43.1
|
-
No YoY
|
1.5%
+12.6
YoY
|
|
700.92M
|
Composite
37.5
Moat
28.9
|
30.16
+7.5
YoY
|
-3.5%
-0.4
YoY
|
|
|
698.45M
|
Composite
65.4
Moat
44.8
|
29.74
-13.0
YoY
|
-15.4%
No YoY
|
|
|
691.50M
|
Composite
45.8
Moat
24.4
|
8.83
-5.0
YoY
|
-
No YoY
|
|
|
689.66M
|
Composite
69.9
Moat
57.0
|
1434.4
+1422.4
YoY
|
-59.1%
-55.4
YoY
|
|
|
680.30M
|
Composite
55.6
Moat
43.4
|
20.43
-2.3
YoY
|
-
No YoY
|
|
|
676.74M
|
Composite
55.5
Moat
50.8
|
44.30
+6.4
YoY
|
-1.9%
+5074.9
YoY
|
|
|
672.56M
|
Composite
69.7
Moat
59.7
|
-
No YoY
|
-
No YoY
|
|
|
669.54M
|
Composite
52.9
Moat
33.1
|
37.50
-8.1
YoY
|
-277.8%
-72.0
YoY
|
|
|
668.20M
|
Composite
57.4
Moat
32.3
|
50.35
+35.8
YoY
|
-
No YoY
|
|
|
663.70M
|
Composite
47.6
Moat
43.7
|
38.53
+14.5
YoY
|
-5.0%
-4.0
YoY
|
|
|
662.01M
|
Composite
47.1
Moat
35.1
|
2.89
-11.2
YoY
|
-7.1%
+11.8
YoY
|
|
|
657.10M
|
Composite
55.1
Moat
38.8
|
19.23
+15.5
YoY
|
-
No YoY
|
|
|
653.20M
|
Composite
40.9
Moat
41.6
|
39.68
No YoY
|
-28.2%
-2.2
YoY
|
|
|
KURA
Kura Oncology, Inc.
|
646.70M
|
Composite
55.4
Moat
45.4
|
125.0
+84.2
YoY
|
-4.5%
-0.9
YoY
|
|
641.36M
|
Composite
56.2
Moat
47.6
|
41.34
-8.6
YoY
|
-
No YoY
|
|
|
638.96M
|
Composite
53.6
Moat
61.4
|
48.53
-19.8
YoY
|
-
No YoY
|
|
|
GERN
Geron Corporation
|
636.00M
|
Composite
59.9
Moat
55.1
|
38.68
+16.4
YoY
|
-37.3%
-35.0
YoY
|
|
EVO
Evotec SE
|
627.05M
|
Composite
45.3
Moat
47.0
|
605.3
No YoY
|
-7.1%
+10.8
YoY
|
|
SOPH
SOPHiA GENETICS SA
|
611.60M
|
Composite
42.9
Moat
35.0
|
23.50
+1.9
YoY
|
-91.8%
-90.7
YoY
|
|
609.93M
|
Composite
53.9
Moat
34.2
|
12.43
-7.7
YoY
|
-
No YoY
|
|
|
591.99M
|
Composite
55.6
Moat
48.9
|
106.5
+26.4
YoY
|
-12.8%
+2.6
YoY
|
|
|
CLYM
Climb Bio, Inc.
|
591.02M
|
Composite
59.9
Moat
59.0
|
22.32
-94.1
YoY
|
-
No YoY
|
|
583.10M
|
Composite
63.8
Moat
72.6
|
-
No YoY
|
8.9%
+1.3
YoY
|
|
|
574.10M
|
Composite
41.3
Moat
18.1
|
23.11
-44.8
YoY
|
-9.8%
-2.2
YoY
|
|
|
572.40M
|
Composite
58.8
Moat
44.4
|
46.59
-32.0
YoY
|
-
No YoY
|
|
|
572.00M
|
Composite
53.0
Moat
72.7
|
-
No YoY
|
16.4%
-8.2
YoY
|
|
|
566.20M
|
Composite
42.2
Moat
48.9
|
141.2
+126.0
YoY
|
-47.0%
-32.2
YoY
|
|
|
561.80M
|
Composite
71.7
Moat
73.1
|
91.81
-9.6
YoY
|
97.6%
+101.5
YoY
|
|
|
SGHT
Sight Sciences, Inc.
|
560.24M
|
Composite
52.0
Moat
59.2
|
37.17
-27.5
YoY
|
-47.9%
+15.3
YoY
|
|
556.60M
|
Composite
54.9
Moat
43.8
|
21.80
+10.4
YoY
|
-5.9%
+103.5
YoY
|
|
|
554.74M
|
Composite
43.8
Moat
32.9
|
1.94
-11.9
YoY
|
-49.1%
-20.1
YoY
|
|
|
ENTX
Entera Bio Ltd.
|
543.70M
|
Composite
45.8
Moat
28.1
|
11.57
-3.7
YoY
|
-274.5%
-221.5
YoY
|
|
SRZN
Surrozen, Inc.
|
542.35M
|
Composite
50.7
Moat
51.7
|
35.41
+11.9
YoY
|
-12.1%
-9.7
YoY
|
|
VALN
Valneva SE
|
530.74M
|
Composite
52.4
Moat
58.0
|
24.88
-5.2
YoY
|
-47.0%
-54.8
YoY
|
|
523.25M
|
Composite
55.9
Moat
48.6
|
54.68
+9.2
YoY
|
-1.9%
+93.7
YoY
|
|
|
518.10M
|
Composite
65.1
Moat
71.1
|
34.20
+21.7
YoY
|
0.8%
+34.1
YoY
|
|
|
518.02M
|
Composite
44.6
Moat
40.8
|
195.5
No YoY
|
-21.9%
-20.3
YoY
|
|
|
RCEL
Avita Medical, Inc.
|
513.10M
|
Composite
42.6
Moat
50.2
|
7.00
-1.8
YoY
|
-59.4%
+28.7
YoY
|
|
512.91M
|
Composite
36.0
Moat
29.2
|
16.38
-6.1
YoY
|
-7.2%
+8.1
YoY
|
|
|
509.89M
|
Composite
48.7
Moat
22.3
|
6.89
+1.3
YoY
|
-
No YoY
|
|
|
509.65M
|
Composite
58.8
Moat
68.6
|
87.90
No YoY
|
9.8%
-5.4
YoY
|
|
|
NGNE
Neurogene Inc.
|
506.49M
|
Composite
50.0
Moat
22.7
|
41.83
-11.3
YoY
|
-89.3%
No YoY
|
|
504.74M
|
Composite
55.5
Moat
50.2
|
24.73
+0.7
YoY
|
-
No YoY
|
|
|
RGNX
REGENXBIO Inc.
|
503.00M
|
Composite
57.9
Moat
54.3
|
22.27
+6.0
YoY
|
-94.6%
-91.8
YoY
|
|
ANGO
AngioDynamics, Inc.
|
493.30M
|
Composite
43.2
Moat
53.0
|
66.22
+33.8
YoY
|
-12.5%
+1.2
YoY
|
|
MDXG
MiMedx Group, Inc
|
483.00M
|
Composite
59.7
Moat
76.2
|
44.23
-483.0
YoY
|
15.3%
-1.6
YoY
|
|
TKNO
Alpha Teknova, Inc.
|
481.90M
|
Composite
50.8
Moat
36.4
|
29.62
+0.2
YoY
|
-41.9%
+27.4
YoY
|
|
479.38M
|
Composite
62.3
Moat
47.6
|
138.1
+25.3
YoY
|
-
No YoY
|
|
|
477.20M
|
Composite
55.0
Moat
59.8
|
21.76
+7.8
YoY
|
-29.3%
-47.4
YoY
|
|
|
STTK
Shattuck Labs, Inc.
|
463.68M
|
Composite
56.1
Moat
40.2
|
23.49
+9.0
YoY
|
-51.5%
-37.4
YoY
|
|
462.37M
|
Composite
51.9
Moat
27.2
|
38.55
+14.3
YoY
|
-
No YoY
|
|
|
454.19M
|
Composite
38.7
Moat
35.4
|
19.08
+4.3
YoY
|
-1.9%
+1.4
YoY
|
|
|
453.70M
|
Composite
43.0
Moat
26.5
|
27.73
+3.7
YoY
|
-1.6%
+51.9
YoY
|
|
|
450.40M
|
Composite
47.2
Moat
39.4
|
15.28
-42.7
YoY
|
-11.0%
+1.9
YoY
|
|
|
BWAY
Brainsway Ltd.
|
441.02M
|
Composite
67.5
Moat
79.5
|
58.50
No YoY
|
8.3%
+4.9
YoY
|
|
MASS
908 Devices Inc.
|
436.48M
|
Composite
51.6
Moat
49.6
|
57.23
+29.9
YoY
|
-70.2%
-68.9
YoY
|
|
NPCE
Neuropace, Inc.
|
429.05M
|
Composite
53.7
Moat
60.8
|
66.57
+31.3
YoY
|
-16.3%
+10.8
YoY
|
|
TLRY
Tilray Brands, Inc.
|
428.25M
|
Composite
46.9
Moat
44.9
|
40.14
+7.6
YoY
|
-6.9%
-4.1
YoY
|
|
428.06M
|
Composite
33.2
Moat
32.7
|
0.15
No YoY
|
-8.0%
-6.8
YoY
|
|
|
425.90M
|
Composite
63.3
Moat
73.7
|
61.47
No YoY
|
16.3%
+2.9
YoY
|
|
|
PRTC
PureTech Health plc
|
423.21M
|
Composite
44.0
Moat
41.3
|
39.09
+6.3
YoY
|
-21.1%
+10.4
YoY
|
|
ARVN
Arvinas, Inc.
|
419.80M
|
Composite
58.5
Moat
60.9
|
30.04
-18.1
YoY
|
-45.1%
+49.9
YoY
|
|
KMDA
Kamada Ltd.
|
417.10M
|
Composite
61.1
Moat
74.6
|
25.29
No YoY
|
14.5%
+2.1
YoY
|
|
417.01M
|
Composite
60.0
Moat
57.4
|
9.35
-4.0
YoY
|
-91.4%
-86.3
YoY
|
|
|
416.01M
|
Composite
60.2
Moat
47.3
|
24.38
+14.0
YoY
|
-
No YoY
|
|
|
415.80M
|
Composite
63.0
Moat
60.0
|
72.45
+46.1
YoY
|
-16.8%
-15.2
YoY
|
|
|
CRMD
CorMedix Inc.
|
414.66M
|
Composite
68.1
Moat
70.3
|
12.25
-11.5
YoY
|
48.2%
+99.6
YoY
|
|
409.20M
|
Composite
53.5
Moat
39.2
|
22.56
-15.1
YoY
|
-22.2%
-21.0
YoY
|
|
|
CERS
Cerus Corporation
|
407.90M
|
Composite
54.1
Moat
61.7
|
18.31
-29.6
YoY
|
-4.2%
+3.7
YoY
|
|
ALT
Altimmune, Inc.
|
404.60M
|
Composite
54.8
Moat
27.8
|
48.59
+28.8
YoY
|
-2304.6%
+2854.0
YoY
|
|
403.50M
|
Composite
58.9
Moat
38.2
|
50.69
+22.0
YoY
|
-
No YoY
|
|
|
394.70M
|
Composite
59.8
Moat
48.8
|
10.65
-4.8
YoY
|
-3.9%
+3.8
YoY
|
|
|
ZURA
Zura Bio Limited
|
393.97M
|
Composite
60.0
Moat
36.0
|
20.26
-55.2
YoY
|
-
No YoY
|
|
TBRG
TruBridge, Inc.
|
393.60M
|
Composite
56.7
Moat
62.3
|
88.46
No YoY
|
6.0%
+4.2
YoY
|
|
381.38M
|
Composite
58.2
Moat
56.7
|
30.22
-14.9
YoY
|
-3.2%
+0.2
YoY
|
|
|
RZLT
Rezolute, Inc.
|
375.30M
|
Composite
53.4
Moat
51.3
|
20.01
-9.1
YoY
|
-
No YoY
|
|
373.81M
|
Composite
63.4
Moat
72.0
|
57.04
-17.8
YoY
|
-32.1%
No YoY
|
|
|
372.70M
|
Composite
63.1
Moat
50.7
|
-
No YoY
|
-89.3%
-98.1
YoY
|
|
|
371.70M
|
Composite
51.2
Moat
25.5
|
22.93
-10.0
YoY
|
-1236.0%
-1080.7
YoY
|
|
|
370.78M
|
Composite
63.1
Moat
41.9
|
22.00
+6.4
YoY
|
-8.6%
+11.3
YoY
|
|
|
365.34M
|
Composite
51.8
Moat
20.6
|
19.77
-7.6
YoY
|
-7483.4%
-1602.2
YoY
|
|
|
359.31M
|
Composite
58.6
Moat
24.1
|
20.12
+2.6
YoY
|
-12418.1%
-8968.3
YoY
|
|
|
EMBC
Embecta Corp.
|
350.72M
|
Composite
46.8
Moat
71.3
|
-
No YoY
|
22.4%
+7.6
YoY
|
|
347.76M
|
Composite
47.2
Moat
46.0
|
15.35
+1.1
YoY
|
-2.7%
+2.9
YoY
|
|
|
AUNA
Auna SA
|
346.38M
|
Composite
49.5
Moat
62.0
|
-
No YoY
|
14.3%
-3.6
YoY
|
|
346.00M
|
Composite
59.3
Moat
69.6
|
-
No YoY
|
8.5%
+0.5
YoY
|
|
|
345.68M
|
Composite
57.2
Moat
52.4
|
27.43
-12.8
YoY
|
39.4%
No YoY
|
|
|
PROK
ProKidney Corp.
|
344.65M
|
Composite
49.9
Moat
35.9
|
26.98
-7.1
YoY
|
-184.8%
+2232.0
YoY
|
|
344.00M
|
Composite
61.8
Moat
54.5
|
35.39
+26.1
YoY
|
-14.1%
-19.5
YoY
|
|
|
340.70M
|
Composite
58.6
Moat
45.1
|
12.73
-21.5
YoY
|
-3.6%
+20.3
YoY
|
|
|
ALEC
Alector, Inc.
|
339.51M
|
Composite
50.2
Moat
43.8
|
16.69
-4.9
YoY
|
-7.4%
-6.0
YoY
|
|
337.79M
|
Composite
47.1
Moat
44.5
|
26.10
+10.2
YoY
|
-1.5%
+22.8
YoY
|
|
|
332.80M
|
Composite
54.0
Moat
32.3
|
130.7
+81.0
YoY
|
-254.4%
-9.8
YoY
|
|
|
328.60M
|
Composite
47.0
Moat
57.6
|
103.8
+79.3
YoY
|
57.2%
-1.8
YoY
|
|
|
324.72M
|
Composite
58.5
Moat
52.1
|
35.46
+26.1
YoY
|
-2.5%
+11.8
YoY
|
|
|
AGEN
Agenus Inc.
|
321.90M
|
Composite
52.8
Moat
58.4
|
0.47
-2.6
YoY
|
-17.7%
-16.5
YoY
|
|
320.57M
|
Composite
49.6
Moat
61.5
|
8.68
-44.0
YoY
|
-9.9%
+0.7
YoY
|
|
|
320.40M
|
Composite
60.9
Moat
59.9
|
117.6
+79.8
YoY
|
-1.3%
+0.5
YoY
|
|
|
316.70M
|
Composite
44.0
Moat
31.6
|
8.91
+4.6
YoY
|
-
No YoY
|
|
|
OCGN
Ocugen, Inc.
|
313.86M
|
Composite
49.2
Moat
32.4
|
3.91
-12.7
YoY
|
-14.3%
-0.8
YoY
|
|
311.70M
|
Composite
40.5
Moat
63.8
|
46.44
No YoY
|
11.9%
+7.6
YoY
|
|
|
311.60M
|
Composite
44.1
Moat
65.7
|
6.50
-219.6
YoY
|
14.2%
+24.9
YoY
|
|
|
304.21M
|
Composite
58.3
Moat
61.4
|
13.53
-7.1
YoY
|
-15.8%
+5.1
YoY
|
|
|
301.80M
|
Composite
54.2
Moat
45.0
|
21.80
-8.2
YoY
|
-4.2%
+0.5
YoY
|
|
|
297.06M
|
Composite
52.6
Moat
46.4
|
0.81
+0.4
YoY
|
-43.5%
+4.6
YoY
|
|
|
296.12M
|
Composite
49.2
Moat
58.1
|
21.07
+3.3
YoY
|
-1.5%
+36.6
YoY
|
|
|
294.18M
|
Composite
46.6
Moat
57.6
|
37.31
-10.3
YoY
|
-1.1%
+68.0
YoY
|
|
|
291.12M
|
Composite
45.0
Moat
49.1
|
20.64
-8.0
YoY
|
-47.7%
-12.2
YoY
|
|
|
SMTI
Sanara MedTech Inc.
|
289.88M
|
Composite
51.0
Moat
55.7
|
8011.2
+7992.2
YoY
|
7.1%
+5.6
YoY
|
|
284.04M
|
Composite
49.0
Moat
60.7
|
24.48
-1.9
YoY
|
-
No YoY
|
|
|
282.30M
|
Composite
54.7
Moat
53.9
|
70.38
-1233.6
YoY
|
-27.4%
+12.1
YoY
|
|
|
277.46M
|
Composite
55.1
Moat
42.0
|
17.21
-29.0
YoY
|
-2.1%
+1.3
YoY
|
|
|
276.07M
|
Composite
44.3
Moat
35.0
|
68.59
+59.1
YoY
|
-56.8%
-13.2
YoY
|
|
|
275.70M
|
Composite
45.2
Moat
43.3
|
23.03
-3.9
YoY
|
-65.4%
-2.5
YoY
|
|
|
275.69M
|
Composite
60.4
Moat
55.9
|
25.89
+18.6
YoY
|
-
No YoY
|
|
|
QTTB
Q32 Bio Inc.
|
275.37M
|
Composite
63.1
Moat
77.4
|
17.28
+3.5
YoY
|
31.4%
+24.2
YoY
|
|
273.11M
|
Composite
56.5
Moat
54.4
|
77.20
+16.1
YoY
|
-
No YoY
|
|
|
272.70M
|
Composite
53.7
Moat
68.2
|
-
No YoY
|
8.3%
+3.2
YoY
|
|
|
269.99M
|
Composite
39.5
Moat
50.5
|
34.82
+8.7
YoY
|
-48.1%
-45.9
YoY
|
|
|
263.53M
|
Composite
57.4
Moat
40.0
|
266.0
No YoY
|
2.9%
-12.5
YoY
|
|
|
263.40M
|
Composite
47.6
Moat
48.8
|
18.76
-9.3
YoY
|
-2.6%
+0.5
YoY
|
|
|
262.09M
|
Composite
46.6
Moat
58.2
|
36.34
+11.9
YoY
|
-25.5%
+1.1
YoY
|
|
|
261.80M
|
Composite
55.3
Moat
42.6
|
11.93
-9.4
YoY
|
-
No YoY
|
|
|
261.29M
|
Composite
59.6
Moat
35.7
|
42.26
+24.8
YoY
|
-23.8%
-12.6
YoY
|
|
|
257.97M
|
Composite
58.4
Moat
54.0
|
35.38
+10.5
YoY
|
-2.5%
-0.3
YoY
|
|
|
254.78M
|
Composite
52.3
Moat
37.2
|
44.47
+27.6
YoY
|
-15.0%
+66.4
YoY
|
|
|
253.04M
|
Composite
46.5
Moat
49.9
|
30.19
-33.9
YoY
|
-3.4%
+2.5
YoY
|
|
|
251.10M
|
Composite
47.6
Moat
36.0
|
30.28
+5.8
YoY
|
-1.3%
+0.1
YoY
|
|
|
249.48M
|
Composite
54.1
Moat
26.9
|
14.51
-16.6
YoY
|
-
No YoY
|
|
|
SPOK
Spok Holdings, Inc.
|
246.10M
|
Composite
58.8
Moat
78.8
|
-
No YoY
|
14.1%
+0.3
YoY
|
|
BIOA
BioAge Labs, Inc.
|
245.09M
|
Composite
43.6
Moat
20.3
|
41.32
-41.2
YoY
|
-10.3%
No YoY
|
|
244.70M
|
Composite
30.9
Moat
20.6
|
113.8
+93.2
YoY
|
-23.5%
+16.7
YoY
|
|
|
243.79M
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
241.08M
|
Composite
42.7
Moat
40.2
|
481.5
+468.3
YoY
|
-13.4%
-6.5
YoY
|
|
|
238.46M
|
Composite
56.7
Moat
39.3
|
30.09
+9.2
YoY
|
-15.4%
-1.9
YoY
|
|
|
238.33M
|
Composite
59.3
Moat
29.4
|
45.74
+37.9
YoY
|
-163.3%
-147.0
YoY
|
|
|
237.30M
|
Composite
40.2
Moat
34.1
|
48.78
+20.6
YoY
|
-62.6%
-47.4
YoY
|
|
|
237.10M
|
Composite
54.2
Moat
27.9
|
22.13
+4.2
YoY
|
-92.5%
-62.0
YoY
|
|
|
HITI
High Tide Inc.
|
235.86M
|
Composite
55.5
Moat
43.7
|
-
No YoY
|
-2.4%
-3.4
YoY
|
|
231.00M
|
Composite
54.9
Moat
61.8
|
28.93
-256.4
YoY
|
-70.0%
-49.5
YoY
|
|
|
229.33M
|
Composite
57.2
Moat
70.1
|
-
No YoY
|
29.6%
-3.6
YoY
|
|
|
227.82M
|
Composite
43.2
Moat
44.2
|
20.31
-87.5
YoY
|
-31.0%
-29.9
YoY
|
|
|
ELMD
Electromed, Inc.
|
227.30M
|
Composite
67.2
Moat
78.6
|
142.6
No YoY
|
18.8%
+3.7
YoY
|
|
222.70M
|
Composite
56.3
Moat
79.4
|
-
No YoY
|
25.1%
-25.4
YoY
|
|
|
222.67M
|
Composite
47.5
Moat
14.9
|
7.48
+0.7
YoY
|
-
No YoY
|
|
|
CABA
Cabaletta Bio, Inc.
|
220.41M
|
Composite
49.2
Moat
30.6
|
12.23
-10.1
YoY
|
-
No YoY
|
|
219.90M
|
Composite
56.6
Moat
42.0
|
23.04
-4.2
YoY
|
-22.2%
-6.8
YoY
|
|
|
KRRO
Korro Bio, Inc.
|
217.20M
|
Composite
54.9
Moat
35.2
|
11.48
-13.7
YoY
|
-19.1%
+21.4
YoY
|
|
ACIU
AC Immune SA
|
214.70M
|
Composite
51.0
Moat
29.3
|
15.84
-4.6
YoY
|
-19.4%
-17.5
YoY
|
|
211.70M
|
Composite
43.5
Moat
35.2
|
25.67
-9.9
YoY
|
-
No YoY
|
|
|
205.78M
|
Composite
44.6
Moat
43.1
|
99.25
-456.3
YoY
|
-18.8%
+23.8
YoY
|
|
|
204.70M
|
Composite
62.9
Moat
62.6
|
30.29
-375.4
YoY
|
-10.4%
-17.8
YoY
|
|
|
202.89M
|
Composite
60.6
Moat
25.5
|
16.89
-23.5
YoY
|
-268.1%
-176.5
YoY
|
|
|
202.57M
|
Composite
46.3
Moat
40.4
|
33.17
+11.7
YoY
|
-42.2%
+43.3
YoY
|
|
|
PDEX
Pro-Dex, Inc.
|
202.10M
|
Composite
58.6
Moat
65.0
|
51.07
+28.3
YoY
|
16.8%
+0.7
YoY
|
|
ADCT
ADC Therapeutics SA
|
201.71M
|
Composite
50.8
Moat
61.5
|
22.21
-2.1
YoY
|
-1.5%
+0.4
YoY
|
|
200.12M
|
Composite
43.7
Moat
66.3
|
13.62
+11.1
YoY
|
-59.7%
-58.5
YoY
|
|
|
199.70M
|
Composite
65.6
Moat
61.2
|
20.67
-5.0
YoY
|
-38.9%
-37.8
YoY
|
|
|
THAR
Tharimmune, Inc.
|
198.86M
|
Composite
56.3
Moat
9.2
|
3.92
-14.1
YoY
|
-
No YoY
|
|
PYXS
Pyxis Oncology, Inc.
|
198.30M
|
Composite
50.3
Moat
41.5
|
12.63
-13.8
YoY
|
-6.1%
-0.6
YoY
|
|
PALI
Palisade Bio, Inc.
|
196.93M
|
Composite
55.5
Moat
36.5
|
147.6
+137.9
YoY
|
-52.3%
No YoY
|
|
EDAP
EDAP TMS S.A.
|
194.90M
|
Composite
33.4
Moat
32.0
|
14.96
-9.4
YoY
|
-35.0%
-3.0
YoY
|
|
194.70M
|
Composite
53.5
Moat
53.6
|
461.3
No YoY
|
-9.8%
-5.6
YoY
|
|
|
IFRX
InflaRx N.V.
|
192.30M
|
Composite
50.4
Moat
12.9
|
15.79
+2.7
YoY
|
-1645.3%
-1325.6
YoY
|
|
190.51M
|
Composite
60.1
Moat
53.9
|
21.01
-28.3
YoY
|
-2.7%
-1.1
YoY
|
|
|
RXST
RxSight, Inc.
|
190.36M
|
Composite
46.7
Moat
55.1
|
176.5
+8.5
YoY
|
-35.8%
-9.5
YoY
|
|
CGEN
Compugen Ltd.
|
185.70M
|
Composite
66.5
Moat
76.1
|
16.95
-12.4
YoY
|
43.0%
+96.5
YoY
|
|
185.58M
|
Composite
49.8
Moat
71.7
|
41.77
+9.9
YoY
|
27.7%
+87.1
YoY
|
|
|
MDWD
MediWound Ltd.
|
184.00M
|
Composite
60.0
Moat
49.3
|
39.56
+1.5
YoY
|
-1.5%
+94.5
YoY
|
|
183.29M
|
Composite
61.8
Moat
47.1
|
114.5
+77.4
YoY
|
-
No YoY
|
|
|
ACOG
Alpha Cognition Inc.
|
180.54M
|
Composite
57.9
Moat
44.9
|
38.89
-36.2
YoY
|
-2.2%
No YoY
|
|
176.91M
|
Composite
50.6
Moat
40.5
|
30.75
-64.7
YoY
|
-56.2%
-23.4
YoY
|
|
|
176.32M
|
Composite
46.1
Moat
51.5
|
27.61
-93.7
YoY
|
-6.2%
-28.5
YoY
|
|
|
PEPG
PepGen Inc.
|
171.07M
|
Composite
56.0
Moat
52.3
|
21.82
+4.3
YoY
|
-
No YoY
|
|
IVVD
Invivyd, Inc.
|
165.95M
|
Composite
60.8
Moat
57.5
|
46.79
+41.9
YoY
|
-1.0%
+5.9
YoY
|
|
165.00M
|
Composite
55.1
Moat
70.1
|
22.96
No YoY
|
10.7%
+25.6
YoY
|
|
|
STIM
Neuronetics, Inc.
|
163.80M
|
Composite
45.8
Moat
44.2
|
16.70
+9.5
YoY
|
-21.1%
+25.1
YoY
|
|
161.90M
|
Composite
60.5
Moat
65.6
|
-
No YoY
|
-1.6%
-2.0
YoY
|
|
|
161.89M
|
Composite
54.0
Moat
53.2
|
23.56
-2.5
YoY
|
-2.8%
No YoY
|
|
|
160.60M
|
Composite
63.3
Moat
45.8
|
165.2
-37.3
YoY
|
-7.5%
+4.2
YoY
|
|
|
INGN
Inogen, Inc
|
160.03M
|
Composite
52.0
Moat
52.2
|
127.9
-348.8
YoY
|
-8.7%
+4.0
YoY
|
|
159.71M
|
Composite
56.8
Moat
31.7
|
6.39
-6.2
YoY
|
-
No YoY
|
|
|
159.50M
|
Composite
48.6
Moat
62.1
|
9.58
-10.3
YoY
|
-1.5%
+2.3
YoY
|
|
|
MOVE
Movano Inc.
|
158.08M
|
Composite
44.5
Moat
10.7
|
3.01
-1.2
YoY
|
-35.8%
-11.9
YoY
|
|
151.90M
|
Composite
41.5
Moat
31.1
|
27.00
No YoY
|
-18.1%
+1.4
YoY
|
|
|
150.94M
|
Composite
51.1
Moat
45.9
|
23.33
+3.0
YoY
|
-
No YoY
|
|
|
MGNX
MacroGenics, Inc.
|
148.42M
|
Composite
56.2
Moat
59.8
|
28.12
-7.3
YoY
|
-48.7%
+25.0
YoY
|
|
148.30M
|
Composite
57.0
Moat
45.8
|
42.70
+9.2
YoY
|
-
No YoY
|
|
|
145.40M
|
Composite
57.5
Moat
42.7
|
19.62
+4.8
YoY
|
-1.8%
+2.8
YoY
|
|
|
142.70M
|
Composite
51.6
Moat
54.0
|
359.6
+331.4
YoY
|
-7.2%
+11.9
YoY
|
|
|
142.66M
|
Composite
53.7
Moat
49.8
|
78.78
-720.1
YoY
|
-4.1%
-2.9
YoY
|
|
|
141.53M
|
Composite
41.6
Moat
58.9
|
201.8
+134.2
YoY
|
-10.2%
+59.2
YoY
|
|
|
XGN
Exagen Inc.
|
140.75M
|
Composite
51.0
Moat
44.9
|
28.38
+8.5
YoY
|
-21.1%
+3.4
YoY
|
|
136.90M
|
Composite
40.1
Moat
38.9
|
18.37
-80.3
YoY
|
-90.5%
-51.7
YoY
|
|
|
136.65M
|
Composite
58.9
Moat
37.8
|
51.01
+17.1
YoY
|
-66.6%
No YoY
|
|
|
136.06M
|
Composite
44.0
Moat
54.1
|
15.02
+7.6
YoY
|
-96.7%
-92.2
YoY
|
|
|
134.74M
|
Composite
55.8
Moat
61.0
|
33.12
-24.0
YoY
|
-
No YoY
|
|
|
ADAG
Adagene Inc.
|
134.29M
|
Composite
56.9
Moat
36.9
|
57.12
+22.7
YoY
|
-2.8%
+345.6
YoY
|
|
133.79M
|
Composite
53.2
Moat
34.6
|
17.61
+9.3
YoY
|
-11.4%
-6.3
YoY
|
|
|
IPHA
Innate Pharma S.A.
|
131.65M
|
Composite
39.6
Moat
32.3
|
12.65
-127.9
YoY
|
-19.4%
-15.3
YoY
|
|
130.51M
|
Composite
35.8
Moat
27.5
|
4.05
+1.1
YoY
|
-
No YoY
|
|
|
MXCT
MaxCyte, Inc.
|
130.04M
|
Composite
48.4
Moat
44.4
|
35.94
-31.2
YoY
|
-1.6%
-0.2
YoY
|
|
126.16M
|
Composite
52.5
Moat
40.0
|
23.24
-3.5
YoY
|
-13.2%
+11.2
YoY
|
|
|
125.63M
|
Composite
42.0
Moat
10.8
|
7.92
-2.9
YoY
|
-1328.7%
-812.5
YoY
|
|
|
FONR
Fonar Corporation
|
125.10M
|
Composite
56.0
Moat
58.8
|
-
No YoY
|
11.1%
-5.0
YoY
|
|
PYPD
PolyPid Ltd.
|
124.71M
|
Composite
51.9
Moat
19.7
|
5.57
-3.0
YoY
|
-
No YoY
|
|
HUMA
Humacyte, Inc.
|
124.51M
|
Composite
48.1
Moat
25.0
|
5.77
+0.3
YoY
|
-53.1%
No YoY
|
|
NKTX
Nkarta, Inc.
|
123.91M
|
Composite
49.4
Moat
67.3
|
37.38
+5.2
YoY
|
-
No YoY
|
|
123.60M
|
Composite
48.9
Moat
44.9
|
45.88
No YoY
|
-5.9%
+15.8
YoY
|
|
|
123.40M
|
Composite
52.2
Moat
50.6
|
47.60
+26.5
YoY
|
-12.2%
+27.0
YoY
|
|
|
123.23M
|
Composite
50.2
Moat
33.4
|
21.79
-8.5
YoY
|
-12.3%
-3.6
YoY
|
|
|
122.76M
|
Composite
47.2
Moat
38.9
|
-
No YoY
|
-92.9%
-90.0
YoY
|
|
|
OWLT
Owlet, Inc.
|
121.85M
|
Composite
55.8
Moat
49.2
|
39.43
+17.8
YoY
|
-7.8%
+18.1
YoY
|
|
119.00M
|
Composite
50.9
Moat
40.2
|
14.91
-59.1
YoY
|
-4.3%
+3.3
YoY
|
|
|
CDXS
Codexis, Inc.
|
118.30M
|
Composite
57.1
Moat
60.3
|
48.44
+30.6
YoY
|
-59.3%
+39.3
YoY
|
|
ENGN
enGene Holdings Inc.
|
117.28M
|
Composite
57.5
Moat
37.2
|
23.43
-35.8
YoY
|
-
No YoY
|
|
116.70M
|
Composite
41.6
Moat
43.9
|
5.29
+4.1
YoY
|
-40.5%
-13.8
YoY
|
|
|
116.04M
|
Composite
61.8
Moat
20.5
|
13.67
-12.3
YoY
|
-
No YoY
|
|
|
115.55M
|
Composite
42.3
Moat
68.0
|
73.10
+60.0
YoY
|
-
No YoY
|
|
|
114.90M
|
Composite
51.3
Moat
52.4
|
17.80
-191.2
YoY
|
-3.3%
-2.2
YoY
|
|
|
114.24M
|
Composite
62.2
Moat
55.2
|
23.98
+2.9
YoY
|
-1.7%
+0.5
YoY
|
|
|
LFMD
LifeMD, Inc.
|
114.20M
|
Composite
42.8
Moat
46.7
|
2.07
-12.9
YoY
|
-4.0%
+9.2
YoY
|
|
111.10M
|
Composite
51.2
Moat
67.1
|
15.31
-6.7
YoY
|
10.0%
+41.5
YoY
|
|
|
111.05M
|
Composite
58.0
Moat
57.3
|
22.15
-7.0
YoY
|
-2.8%
+1.7
YoY
|
|
|
111.04M
|
Composite
41.9
Moat
31.1
|
10.77
-3.9
YoY
|
-490.9%
No YoY
|
|
|
110.40M
|
Composite
56.5
Moat
35.4
|
25.39
-7.2
YoY
|
-52.4%
-26.8
YoY
|
|
|
BGM
BGM Group Ltd.
|
110.17M
|
Composite
49.9
Moat
37.5
|
54.70
No YoY
|
-33.2%
-30.9
YoY
|
|
109.97M
|
Composite
56.6
Moat
47.3
|
50.72
+8.5
YoY
|
-4.8%
+65.1
YoY
|
|
|
HCAT
Health Catalyst, Inc
|
109.87M
|
Composite
38.2
Moat
47.3
|
115.3
-8.4
YoY
|
-51.7%
-28.9
YoY
|
|
STXS
Stereotaxis, Inc.
|
109.20M
|
Composite
39.0
Moat
33.0
|
11.77
-5.5
YoY
|
-68.3%
+23.6
YoY
|
|
107.49M
|
Composite
50.6
Moat
37.3
|
25.93
-3.1
YoY
|
-40.2%
+20.9
YoY
|
|
|
106.60M
|
Composite
57.7
Moat
52.3
|
31.53
-20.0
YoY
|
-
No YoY
|
|
|
106.24M
|
Composite
35.5
Moat
30.6
|
1.87
-0.7
YoY
|
-47.4%
No YoY
|
|
|
IMUX
Immunic, Inc.
|
105.74M
|
Composite
48.5
Moat
54.7
|
2.17
-2.9
YoY
|
-
No YoY
|
|
104.64M
|
Composite
42.4
Moat
66.4
|
109.0
No YoY
|
7.9%
+8.2
YoY
|
|
|
103.87M
|
Composite
54.8
Moat
32.6
|
-
No YoY
|
-
No YoY
|
|
|
102.97M
|
Composite
44.3
Moat
39.1
|
6.63
+5.0
YoY
|
-13.2%
No YoY
|
|
|
99.68M
|
Composite
58.4
Moat
84.0
|
18.99
-4.6
YoY
|
17.9%
No YoY
|
|
|
98.89M
|
Composite
54.8
Moat
26.8
|
15.81
+4.8
YoY
|
-30.8%
-11.8
YoY
|
|
|
98.39M
|
Composite
44.2
Moat
26.2
|
3.93
+1.9
YoY
|
-338.5%
-326.2
YoY
|
|
|
CCLD
CareCloud, Inc.
|
97.70M
|
Composite
58.2
Moat
69.4
|
-
No YoY
|
9.4%
+1.2
YoY
|
|
JYNT
The Joint Corp.
|
96.90M
|
Composite
54.0
Moat
37.9
|
-
No YoY
|
-1.7%
+2.0
YoY
|
|
96.81M
|
Composite
48.2
Moat
31.5
|
32.70
-44.1
YoY
|
-
No YoY
|
|
|
VANI
Vivani Medical, Inc.
|
96.52M
|
Composite
58.9
Moat
45.5
|
8.01
-2.6
YoY
|
-
No YoY
|
|
95.90M
|
Composite
44.3
Moat
25.0
|
21.06
-127.8
YoY
|
-2.1%
0.0
YoY
|
|
|
95.70M
|
Composite
64.2
Moat
64.2
|
15.97
+1.7
YoY
|
-20.1%
+20.1
YoY
|
|
|
95.15M
|
Composite
53.9
Moat
51.7
|
18.42
-21.2
YoY
|
-
No YoY
|
|
|
93.52M
|
Composite
54.3
Moat
25.2
|
10.61
-9.6
YoY
|
-
No YoY
|
|
|
SEER
Seer, Inc.
|
90.26M
|
Composite
52.3
Moat
51.0
|
50.19
-11.3
YoY
|
-4.8%
+2.3
YoY
|
|
CBUS
Cibus, Inc.
|
90.19M
|
Composite
50.5
Moat
37.6
|
2.35
-0.6
YoY
|
-26.8%
+33.8
YoY
|
|
BDSX
Biodesix, Inc.
|
90.00M
|
Composite
45.4
Moat
51.3
|
9.79
+3.3
YoY
|
-31.5%
+16.9
YoY
|
|
89.98M
|
Composite
61.1
Moat
72.8
|
13.87
+7.1
YoY
|
7.6%
+9.9
YoY
|
|
|
89.30M
|
Composite
53.3
Moat
33.6
|
19.96
+16.0
YoY
|
-
No YoY
|
|
|
89.14M
|
Composite
42.0
Moat
36.7
|
11.55
-2.7
YoY
|
-
No YoY
|
|
|
ICCC
ImmuCell Corporation
|
89.00M
|
Composite
66.5
Moat
69.2
|
2.51
-42.5
YoY
|
6.0%
+12.2
YoY
|
|
88.19M
|
Composite
40.0
Moat
8.5
|
3.75
-25.5
YoY
|
-
No YoY
|
|
|
87.97M
|
Composite
45.3
Moat
33.1
|
16.20
No YoY
|
-
No YoY
|
|
|
GNLX
Genelux Corporation
|
87.83M
|
Composite
50.2
Moat
14.0
|
6.93
-10.5
YoY
|
-4151.8%
-189.8
YoY
|
|
86.39M
|
Composite
44.0
Moat
18.0
|
18.36
-20.7
YoY
|
-450.7%
+25.1
YoY
|
|
|
RLYB
Rallybio Corporation
|
84.80M
|
Composite
55.9
Moat
40.6
|
22.03
+6.1
YoY
|
-38.5%
+56.6
YoY
|
|
NYXH
Nyxoah SA
|
84.13M
|
Composite
40.0
Moat
45.4
|
8.35
-12.5
YoY
|
-8.3%
+4.7
YoY
|
|
81.30M
|
Composite
55.1
Moat
41.2
|
24.96
+5.5
YoY
|
-9.6%
+4.0
YoY
|
|
|
80.77M
|
Composite
49.2
Moat
31.7
|
17.68
+9.5
YoY
|
-
No YoY
|
|
|
79.51M
|
Composite
44.7
Moat
44.0
|
43.76
+27.4
YoY
|
-55.8%
+43.9
YoY
|
|
|
79.00M
|
Composite
49.1
Moat
55.8
|
2.00
-5.4
YoY
|
29.7%
+94.4
YoY
|
|
|
NRXS
Neuraxis, Inc.
|
78.36M
|
Composite
65.3
Moat
43.6
|
9.26
+2.0
YoY
|
-2.2%
+0.5
YoY
|
|
78.21M
|
Composite
38.7
Moat
53.5
|
352.1
No YoY
|
-6.3%
+10.7
YoY
|
|
|
CLLS
Cellectis S.A.
|
77.80M
|
Composite
51.6
Moat
53.4
|
63.55
-35.3
YoY
|
-45.3%
-43.9
YoY
|
|
HYPR
Hyperfine, Inc.
|
76.30M
|
Composite
43.7
Moat
37.6
|
15.06
+3.4
YoY
|
-2.7%
+0.6
YoY
|
|
76.00M
|
Composite
38.4
Moat
33.9
|
8.96
+2.9
YoY
|
-10.5%
+0.0
YoY
|
|
|
OKYO
OKYO Pharma Limited
|
75.05M
|
Composite
52.3
Moat
31.2
|
41.63
+31.3
YoY
|
-
No YoY
|
|
74.55M
|
Composite
43.5
Moat
38.5
|
72.29
+64.9
YoY
|
-
No YoY
|
|
|
72.19M
|
Composite
43.5
Moat
61.1
|
2.59
-4.9
YoY
|
-3.1%
-1.3
YoY
|
|
|
71.98M
|
Composite
62.6
Moat
56.4
|
14.48
+5.9
YoY
|
-1.1%
+0.8
YoY
|
|
|
MNOV
MediciNova, Inc.
|
71.86M
|
Composite
52.1
Moat
37.5
|
37.68
-7.8
YoY
|
-32.4%
-22.5
YoY
|
|
71.09M
|
Composite
44.8
Moat
32.0
|
-
No YoY
|
-60.6%
-69.4
YoY
|
|
|
70.14M
|
Composite
54.0
Moat
48.9
|
52.32
+7.6
YoY
|
-2.8%
+2.0
YoY
|
|
|
69.60M
|
Composite
57.1
Moat
53.0
|
13.20
-4.5
YoY
|
-
No YoY
|
|
|
69.45M
|
Composite
49.5
Moat
36.9
|
8.86
+7.9
YoY
|
-9.6%
+177.7
YoY
|
|
|
68.99M
|
Composite
55.0
Moat
50.8
|
22.35
-10.4
YoY
|
-
No YoY
|
|
|
68.33M
|
Composite
33.1
Moat
13.7
|
3.84
-3.6
YoY
|
-47.1%
No YoY
|
|
|
FORA
Forian Inc.
|
67.60M
|
Composite
45.5
Moat
42.3
|
28.24
+6.6
YoY
|
-12.4%
+22.2
YoY
|
|
NTRB
Nutriband Inc.
|
67.46M
|
Composite
56.3
Moat
44.1
|
10.69
-0.5
YoY
|
-4.1%
+0.7
YoY
|
|
LNSR
LENSAR, Inc.
|
66.96M
|
Composite
51.2
Moat
43.4
|
14.55
-103.9
YoY
|
-42.1%
-22.1
YoY
|
|
66.70M
|
Composite
58.0
Moat
62.5
|
13.07
+8.0
YoY
|
-1.9%
-9.9
YoY
|
|
|
ECOR
electroCore, Inc.
|
65.40M
|
Composite
44.0
Moat
51.3
|
17.02
-4.1
YoY
|
-41.1%
+7.2
YoY
|
|
65.33M
|
Composite
57.0
Moat
21.3
|
17.96
+7.4
YoY
|
-
No YoY
|
|
|
64.48M
|
Composite
56.4
Moat
7.1
|
5.51
-1.8
YoY
|
-
No YoY
|
|
|
63.11M
|
Composite
59.8
Moat
37.6
|
31.88
+22.5
YoY
|
-23.5%
+28.4
YoY
|
|
|
CING
Cingulate Inc.
|
61.95M
|
Composite
58.2
Moat
11.5
|
7.62
-0.3
YoY
|
-
No YoY
|
|
61.80M
|
Composite
47.8
Moat
34.1
|
18.45
-10.8
YoY
|
-82.6%
-11.3
YoY
|
|
|
61.70M
|
Composite
61.5
Moat
56.4
|
14.48
+5.9
YoY
|
-1.1%
+0.8
YoY
|
|
|
61.30M
|
Composite
26.4
Moat
27.2
|
1.19
-4.3
YoY
|
-1.0%
+57.3
YoY
|
|
|
59.98M
|
Composite
56.3
Moat
63.8
|
38.27
+11.2
YoY
|
10.6%
+13.3
YoY
|
|
|
GOSS
Gossamer Bio, Inc.
|
59.76M
|
Composite
44.4
Moat
46.3
|
9.59
-1009.5
YoY
|
-3.5%
+48.7
YoY
|
|
59.38M
|
Composite
53.2
Moat
34.6
|
30.38
-12.4
YoY
|
-63.5%
No YoY
|
|
|
XBIT
XBiotech Inc.
|
57.60M
|
Composite
51.5
Moat
45.6
|
37.74
-29.2
YoY
|
-8.6%
-7.2
YoY
|
|
57.25M
|
Composite
50.7
Moat
52.2
|
1.00
-7.2
YoY
|
-59.7%
-20.5
YoY
|
|
|
56.72M
|
Composite
59.6
Moat
50.9
|
330.6
+294.5
YoY
|
-95.9%
-86.4
YoY
|
|
|
56.21M
|
Composite
57.3
Moat
21.8
|
0.26
+0.2
YoY
|
-
No YoY
|
|
|
56.00M
|
Composite
46.0
Moat
55.4
|
3.10
-6.5
YoY
|
-
No YoY
|
|
|
BOLD
Boundless Bio, Inc.
|
55.96M
|
Composite
50.4
Moat
37.2
|
27.67
-2.3
YoY
|
-
No YoY
|
|
55.60M
|
Composite
54.4
Moat
62.1
|
20.28
-11.3
YoY
|
-1.6%
+6.3
YoY
|
|
|
COCH
Envoy Medical, Inc.
|
55.19M
|
Composite
36.1
Moat
21.4
|
2.47
-1.2
YoY
|
-92.4%
-6.8
YoY
|
|
54.80M
|
Composite
54.9
Moat
51.5
|
20.52
+11.4
YoY
|
-34.2%
-25.5
YoY
|
|
|
TLPH
Talphera, Inc.
|
54.50M
|
Composite
39.4
Moat
12.7
|
21.52
+13.1
YoY
|
-481.6%
-455.6
YoY
|
|
53.88M
|
Composite
42.1
Moat
26.7
|
8.58
No YoY
|
-
No YoY
|
|
|
53.86M
|
Composite
49.7
Moat
44.5
|
16.66
-4.7
YoY
|
-15.9%
No YoY
|
|
|
53.63M
|
Composite
44.2
Moat
39.4
|
76.18
+69.9
YoY
|
-11.1%
+18.0
YoY
|
|
|
52.94M
|
Composite
48.7
Moat
56.4
|
1.99
-4.9
YoY
|
-
No YoY
|
|
|
52.82M
|
Composite
54.8
Moat
55.0
|
27.06
+21.3
YoY
|
-
No YoY
|
|
|
52.28M
|
Composite
64.3
Moat
27.7
|
-
No YoY
|
-
No YoY
|
|
|
RNXT
RenovoRx, Inc.
|
51.00M
|
Composite
58.8
Moat
30.5
|
7.68
-1.7
YoY
|
-11.1%
+244.0
YoY
|
|
ZTEK
Zentek Ltd.
|
50.80M
|
Composite
38.5
Moat
28.4
|
3.08
+2.9
YoY
|
-59.8%
-48.8
YoY
|
|
50.14M
|
Composite
53.7
Moat
35.4
|
17.85
-9.6
YoY
|
-116.5%
-103.4
YoY
|
|
|
ATHA
Athira Pharma, Inc.
|
50.13M
|
Composite
52.6
Moat
32.0
|
6.33
-11.2
YoY
|
-
No YoY
|
|
49.33M
|
Composite
57.7
Moat
69.4
|
-
No YoY
|
29.2%
+3.4
YoY
|
|
|
49.09M
|
Composite
57.4
Moat
30.6
|
11.35
-12.4
YoY
|
-39.0%
-37.0
YoY
|
|
|
49.02M
|
Composite
42.1
Moat
28.6
|
0.22
-1.1
YoY
|
-11.5%
-6.6
YoY
|
|
|
48.10M
|
Composite
53.0
Moat
40.5
|
15.06
-3.1
YoY
|
-13.3%
+3.4
YoY
|
|
|
MDAI
Spectral AI, Inc.
|
47.96M
|
Composite
38.9
Moat
42.3
|
18.62
+11.9
YoY
|
-43.8%
-21.5
YoY
|
|
MYO
Myomo Inc.
|
47.90M
|
Composite
44.1
Moat
41.4
|
15.21
-75.5
YoY
|
-35.2%
-16.1
YoY
|
|
IBIO
iBio, Inc.
|
47.50M
|
Composite
47.9
Moat
27.4
|
45.50
+38.8
YoY
|
-351.4%
-304.9
YoY
|
|
47.10M
|
Composite
39.0
Moat
46.3
|
318.5
+189.0
YoY
|
-37.5%
-56.9
YoY
|
|
|
46.98M
|
Composite
34.1
Moat
19.6
|
11.34
+9.3
YoY
|
-1321.5%
No YoY
|
|
|
TIL
Instil Bio, Inc.
|
46.32M
|
Composite
51.1
Moat
60.3
|
24.95
+0.5
YoY
|
-
No YoY
|
|
46.21M
|
Composite
44.3
Moat
66.7
|
0.23
-8.9
YoY
|
-
No YoY
|
|
|
45.89M
|
Composite
51.0
Moat
19.7
|
10.39
-37.2
YoY
|
-907.4%
-821.2
YoY
|
|
|
45.19M
|
Composite
44.3
Moat
27.6
|
15.88
-9.6
YoY
|
-80.2%
-77.4
YoY
|
|
|
45.00M
|
Composite
56.2
Moat
26.3
|
23.43
-3.0
YoY
|
-402.7%
+238.2
YoY
|
|
|
44.95M
|
Composite
51.5
Moat
25.1
|
13.54
+6.9
YoY
|
-403.3%
-276.4
YoY
|
|
|
44.00M
|
Composite
49.1
Moat
44.8
|
34.75
+22.7
YoY
|
-3.5%
No YoY
|
|
|
43.51M
|
Composite
49.3
Moat
38.1
|
5.01
-15.3
YoY
|
-
No YoY
|
|
|
APLM
Apollomics Inc.
|
41.72M
|
Composite
44.1
Moat
55.5
|
3.79
-0.3
YoY
|
-1.1%
No YoY
|
|
INCR
Intercure Ltd.
|
41.18M
|
Composite
51.3
Moat
42.3
|
14.10
-8.6
YoY
|
-10.1%
+18.1
YoY
|
|
BMEA
Biomea Fusion, Inc.
|
41.08M
|
Composite
53.8
Moat
33.2
|
9.52
+3.7
YoY
|
-
No YoY
|
|
EXOZ
eXoZymes, Inc.
|
40.84M
|
Composite
56.6
Moat
19.7
|
5.61
-8.1
YoY
|
-
No YoY
|
|
40.60M
|
Composite
44.7
Moat
69.7
|
6.25
-1.0
YoY
|
5.4%
+15.7
YoY
|
|
|
40.45M
|
Composite
43.5
Moat
35.4
|
1.71
+0.3
YoY
|
-36.3%
-32.0
YoY
|
|
|
39.69M
|
Composite
53.7
Moat
25.2
|
6.03
+0.3
YoY
|
-
No YoY
|
|
|
39.40M
|
Composite
46.1
Moat
40.2
|
-
No YoY
|
1.5%
-9.3
YoY
|
|
|
39.37M
|
Composite
58.2
Moat
62.7
|
49.18
+24.8
YoY
|
-
No YoY
|
|
|
38.90M
|
Composite
43.6
Moat
57.0
|
22.97
+5.1
YoY
|
-83.8%
No YoY
|
|
|
38.49M
|
Composite
41.1
Moat
26.0
|
-
No YoY
|
-7.6%
-6.7
YoY
|
|
|
38.23M
|
Composite
55.5
Moat
46.3
|
25.21
-2.9
YoY
|
-
No YoY
|
|
|
38.06M
|
Composite
38.8
Moat
37.1
|
-
No YoY
|
-56.1%
-49.5
YoY
|
|
|
37.30M
|
Composite
48.9
Moat
40.4
|
2.62
-3.3
YoY
|
-
No YoY
|
|
|
ELUT
Elutia, Inc.
|
37.09M
|
Composite
44.6
Moat
29.5
|
9.73
+2.7
YoY
|
-2.2%
-0.1
YoY
|
|
TELA
TELA Bio, Inc.
|
37.02M
|
Composite
39.5
Moat
51.7
|
21.62
+6.4
YoY
|
-42.0%
+7.2
YoY
|
|
SNPX
Synaptogenix, Inc.
|
36.76M
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
VERU
Veru Inc.
|
36.10M
|
Composite
58.4
Moat
39.0
|
7.32
-6.9
YoY
|
-5.8%
-3.6
YoY
|
|
ANVS
Annovis Bio, Inc.
|
36.00M
|
Composite
47.6
Moat
29.6
|
9.15
+3.4
YoY
|
-
No YoY
|
|
35.05M
|
Composite
51.4
Moat
56.0
|
3.19
+0.6
YoY
|
-1.0%
+3.5
YoY
|
|
|
35.03M
|
Composite
52.4
Moat
21.2
|
0.02
-8.4
YoY
|
-133.8%
-65.7
YoY
|
|
|
SCYX
SCYNEXIS, Inc.
|
34.80M
|
Composite
43.1
Moat
34.3
|
90.93
+61.3
YoY
|
-78.0%
-68.1
YoY
|
|
INMB
INmune Bio Inc.
|
34.75M
|
Composite
49.2
Moat
22.4
|
13.15
+5.6
YoY
|
-947.7%
+2097.7
YoY
|
|
34.50M
|
Composite
46.2
Moat
58.6
|
0.43
-10.3
YoY
|
-
No YoY
|
|
|
33.94M
|
Composite
51.1
Moat
57.1
|
5.91
-2.9
YoY
|
-45.3%
-3.8
YoY
|
|
|
NNVC
NanoViricides, Inc.
|
33.70M
|
Composite
54.1
Moat
24.3
|
4.36
+2.2
YoY
|
-
No YoY
|
|
33.60M
|
Composite
46.2
Moat
46.8
|
23.22
-50.0
YoY
|
-2.1%
+0.6
YoY
|
|
|
PRPO
Precipio, Inc.
|
33.33M
|
Composite
51.9
Moat
54.0
|
5.06
-0.3
YoY
|
-5.0%
+17.8
YoY
|
|
ACET
Adicet Bio, Inc.
|
32.83M
|
Composite
59.1
Moat
49.3
|
19.97
-2.9
YoY
|
-2.9%
+3.4
YoY
|
|
NSPR
InspireMD Inc.
|
32.40M
|
Composite
40.9
Moat
26.2
|
18.53
-0.5
YoY
|
-5.5%
-0.7
YoY
|
|
32.27M
|
Composite
44.8
Moat
51.3
|
5.14
-10.2
YoY
|
-
No YoY
|
|
|
32.16M
|
Composite
39.4
Moat
35.9
|
14.79
+1.0
YoY
|
-1.4%
+0.4
YoY
|
|
|
31.96M
|
Composite
52.0
Moat
56.1
|
4.89
+3.2
YoY
|
-0.8%
-0.7
YoY
|
|
|
31.20M
|
Composite
48.9
Moat
48.1
|
455.2
+441.2
YoY
|
-6.8%
-7.4
YoY
|
|
|
31.00M
|
Composite
46.6
Moat
44.7
|
15.30
-20.0
YoY
|
-7.8%
-4.4
YoY
|
|
|
ONMD
OneMedNet Corp
|
30.90M
|
Composite
38.0
Moat
23.8
|
1.74
-3.5
YoY
|
-7.1%
+7.8
YoY
|
|
COSM
Cosmos Health Inc.
|
30.68M
|
Composite
35.3
Moat
28.4
|
1.08
+0.6
YoY
|
-25.6%
+3.0
YoY
|
|
BTMD
Biote Corp.
|
30.40M
|
Composite
32.8
Moat
69.3
|
103.8
No YoY
|
18.5%
+2.5
YoY
|
|
NEPH
Nephros, Inc.
|
30.30M
|
Composite
53.2
Moat
60.9
|
91.71
+78.2
YoY
|
6.1%
+6.1
YoY
|
|
29.00M
|
Composite
36.5
Moat
28.0
|
3.29
-0.9
YoY
|
-18.5%
+2.8
YoY
|
|
|
EDSA
Edesa Biotech, Inc.
|
28.91M
|
Composite
45.2
Moat
51.9
|
17.69
+15.1
YoY
|
-47362.7%
No YoY
|
|
28.10M
|
Composite
36.5
Moat
19.5
|
63.15
+58.7
YoY
|
-276.6%
+2226.8
YoY
|
|
|
FGEN
FibroGen, Inc
|
27.90M
|
Composite
54.8
Moat
52.0
|
4.39
-3.4
YoY
|
-5.1%
+1.8
YoY
|
|
27.53M
|
Composite
50.3
Moat
30.5
|
4.97
+0.9
YoY
|
-
No YoY
|
|
|
PLRZ
Polyrizon Ltd.
|
26.82M
|
Composite
53.7
Moat
33.7
|
33.03
+6.3
YoY
|
-
No YoY
|
|
26.80M
|
Composite
39.2
Moat
39.9
|
4.58
-8.8
YoY
|
-63.5%
+14.8
YoY
|
|
|
MGX
Metagenomi, Inc.
|
26.80M
|
Composite
56.1
Moat
51.4
|
-
No YoY
|
-1.7%
+0.1
YoY
|
|
26.61M
|
Composite
36.1
Moat
6.0
|
0.42
-2.7
YoY
|
-
No YoY
|
|
|
PETS
PetMed Express, Inc.
|
26.40M
|
Composite
30.7
Moat
32.6
|
9.05
No YoY
|
-32.8%
-29.8
YoY
|
|
26.06M
|
Composite
47.3
Moat
48.5
|
17.62
-28.3
YoY
|
-4.5%
+100.1
YoY
|
|
|
ABVC
ABVC Biopharma, Inc.
|
25.90M
|
Composite
54.0
Moat
40.5
|
3.00
+0.9
YoY
|
-9.2%
+35.2
YoY
|
|
25.90M
|
Composite
45.1
Moat
25.3
|
5.92
+0.9
YoY
|
-78.6%
-48.9
YoY
|
|
|
BYSI
BeyondSpring, Inc.
|
25.74M
|
Composite
43.8
Moat
40.3
|
7.62
+5.5
YoY
|
-27.6%
+21.5
YoY
|
|
MEIP
MEI Pharma, Inc.
|
25.70M
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
25.61M
|
Composite
56.8
Moat
36.2
|
24.37
-24.5
YoY
|
-
No YoY
|
|
|
YI
111, Inc.
|
25.51M
|
Composite
32.7
Moat
47.2
|
17.54
-438.3
YoY
|
-0.0%
-0.0
YoY
|
|
25.50M
|
Composite
48.9
Moat
30.0
|
7.68
+4.7
YoY
|
-
No YoY
|
|
|
25.42M
|
Composite
55.0
Moat
32.6
|
11.32
+2.9
YoY
|
-40.2%
-17.7
YoY
|
|
|
25.23M
|
Composite
45.6
Moat
18.4
|
10.95
+5.7
YoY
|
-
No YoY
|
|
|
EVAX
Evaxion Biotech A/S
|
25.02M
|
Composite
54.7
Moat
55.3
|
42.08
+36.6
YoY
|
-1.2%
+3.2
YoY
|
|
CELU
Celularity Inc.
|
24.67M
|
Composite
50.0
Moat
54.5
|
5.59
+4.2
YoY
|
-2.3%
+68.4
YoY
|
|
IMMP
Immutep Limited
|
24.60M
|
Composite
47.6
Moat
36.7
|
62.68
+21.4
YoY
|
-5.6%
+19.5
YoY
|
|
24.50M
|
Composite
41.6
Moat
29.3
|
18.53
-5.9
YoY
|
-78.2%
-77.1
YoY
|
|
|
NXTC
NextCure, Inc.
|
24.40M
|
Composite
51.8
Moat
40.6
|
10.11
-10.1
YoY
|
-
No YoY
|
|
DCGO
DocGo Inc.
|
24.24M
|
Composite
32.0
Moat
32.1
|
11.03
-1070.6
YoY
|
-55.3%
-59.9
YoY
|
|
23.97M
|
Composite
31.4
Moat
16.2
|
28.39
+22.3
YoY
|
-
No YoY
|
|
|
DRIO
DarioHealth Corp.
|
23.30M
|
Composite
36.1
Moat
30.3
|
12.04
+3.2
YoY
|
-1.6%
+0.5
YoY
|
|
CVRX
CVRx, Inc.
|
23.14M
|
Composite
47.5
Moat
49.3
|
22.62
-9.9
YoY
|
-90.5%
-89.3
YoY
|
|
BEAT
Heartbeam, Inc.
|
22.65M
|
Composite
45.7
Moat
14.4
|
3.76
+1.8
YoY
|
-
No YoY
|
|
22.41M
|
Composite
45.3
Moat
37.2
|
10.51
-11.2
YoY
|
-52.2%
+34.9
YoY
|
|
|
CRVO
CervoMed Inc.
|
21.47M
|
Composite
50.4
Moat
17.1
|
10.68
-17.6
YoY
|
-
No YoY
|
|
21.20M
|
Composite
44.2
Moat
33.5
|
16.65
-23.9
YoY
|
-
No YoY
|
|
|
IGC
IGC Pharma, Inc.
|
20.70M
|
Composite
49.9
Moat
39.4
|
1.20
-1.6
YoY
|
-5.9%
+1.4
YoY
|
|
TXMD
TherapeuticsMD, Inc.
|
20.10M
|
Composite
60.6
Moat
41.9
|
2.25
-3.2
YoY
|
-1.5%
+2.0
YoY
|
|
20.03M
|
Composite
43.5
Moat
24.5
|
10.29
+3.1
YoY
|
-
No YoY
|
|
|
AYTU
Aytu BioPharma, Inc.
|
19.89M
|
Composite
44.3
Moat
41.5
|
191.8
+18.8
YoY
|
-14.4%
-2.6
YoY
|
|
19.70M
|
Composite
56.5
Moat
31.5
|
2.49
-10.6
YoY
|
-119.1%
-74.6
YoY
|
|
|
19.34M
|
Composite
50.1
Moat
37.6
|
43.51
+37.5
YoY
|
-299.3%
No YoY
|
|
|
18.70M
|
Composite
54.8
Moat
34.9
|
4.46
-9.3
YoY
|
-
No YoY
|
|
|
18.14M
|
Composite
47.2
Moat
34.2
|
7.88
-4.2
YoY
|
-
No YoY
|
|
|
18.08M
|
Composite
48.4
Moat
12.6
|
8.22
+3.5
YoY
|
-
No YoY
|
|
|
BIVI
BioVie Inc.
|
17.91M
|
Composite
37.1
Moat
17.6
|
5.66
-5.4
YoY
|
-
No YoY
|
|
17.78M
|
Composite
50.0
Moat
48.5
|
30.01
-47.8
YoY
|
-
No YoY
|
|
|
17.54M
|
Composite
46.4
Moat
31.6
|
16.61
-4.9
YoY
|
-
No YoY
|
|
|
NNOX
NANO-X IMAGING LTD
|
17.40M
|
Composite
40.7
Moat
37.6
|
17.54
-6.5
YoY
|
-6.0%
-1.0
YoY
|
|
16.93M
|
Composite
42.3
Moat
24.5
|
62.80
+16.5
YoY
|
-55.3%
+8.5
YoY
|
|
|
16.91M
|
Composite
42.0
Moat
46.6
|
8.28
-1.0
YoY
|
-4.7%
+4.8
YoY
|
|
|
16.84M
|
Composite
43.4
Moat
28.9
|
5.91
+3.4
YoY
|
-
No YoY
|
|
|
16.67M
|
Composite
50.8
Moat
52.9
|
11.73
+2.8
YoY
|
-2.4%
-0.6
YoY
|
|
|
LFWD
Lifeward Ltd.
|
16.45M
|
Composite
34.3
Moat
37.5
|
1.55
-2.2
YoY
|
-89.3%
-88.1
YoY
|
|
16.32M
|
Composite
46.1
Moat
55.8
|
9.30
No YoY
|
-
No YoY
|
|
|
16.17M
|
Composite
52.8
Moat
38.3
|
12.14
-11.7
YoY
|
-
No YoY
|
|
|
16.11M
|
Composite
34.6
Moat
17.3
|
17.71
+7.1
YoY
|
-56.8%
-55.4
YoY
|
|
|
16.00M
|
Composite
33.3
Moat
16.7
|
3.44
-9.1
YoY
|
-
No YoY
|
|
|
ATYR
aTyr Pharma, Inc.
|
15.60M
|
Composite
50.5
Moat
23.4
|
15.23
+2.7
YoY
|
-408.6%
-119.6
YoY
|
|
15.35M
|
Composite
48.7
Moat
20.6
|
11.89
-1.6
YoY
|
-39.4%
No YoY
|
|
|
PLUR
Pluri Inc.
|
15.25M
|
Composite
41.0
Moat
28.3
|
4.78
-8.8
YoY
|
-24.5%
-7.9
YoY
|
|
15.10M
|
Composite
39.9
Moat
52.4
|
6.06
+3.3
YoY
|
-39.8%
+6.4
YoY
|
|
|
15.04M
|
Composite
50.1
Moat
42.6
|
19.30
+9.0
YoY
|
-14.0%
-6.8
YoY
|
|
|
FLGC
Flora Growth Corp.
|
15.02M
|
Composite
45.0
Moat
29.3
|
14.35
+8.1
YoY
|
-26.3%
+39.9
YoY
|
|
MDXH
MDxHealth SA
|
14.98M
|
Composite
38.5
Moat
52.2
|
159.2
+128.8
YoY
|
-13.4%
+14.1
YoY
|
|
14.96M
|
Composite
50.9
Moat
35.7
|
1.92
+0.5
YoY
|
-
No YoY
|
|
|
14.90M
|
Composite
50.7
Moat
40.4
|
16.05
-5.1
YoY
|
-4.4%
No YoY
|
|
|
SYRA
Syra Health Corp.
|
13.89M
|
Composite
55.8
Moat
20.6
|
43.28
+33.5
YoY
|
-12.5%
+34.7
YoY
|
|
HOOK
HOOKIPA Pharma Inc.
|
13.86M
|
Composite
58.4
Moat
53.4
|
6.19
-18.2
YoY
|
-1.2%
+3.7
YoY
|
|
HSCS
HeartSciences Inc.
|
13.58M
|
Composite
31.8
Moat
18.1
|
2.68
+0.9
YoY
|
-1947.9%
-27.7
YoY
|
|
13.50M
|
Composite
34.0
Moat
36.0
|
14.15
+12.5
YoY
|
-1.2%
+2.2
YoY
|
|
|
SYBX
Synlogic, Inc.
|
13.47M
|
Composite
49.4
Moat
21.4
|
40.38
+33.2
YoY
|
-5118.8%
-5102.4
YoY
|
|
13.26M
|
Composite
45.4
Moat
33.3
|
10.87
+4.4
YoY
|
-
No YoY
|
|
|
ARAY
Accuray Incorporated
|
13.10M
|
Composite
41.9
Moat
48.9
|
69.83
+0.7
YoY
|
-6.6%
-8.3
YoY
|
|
BCDA
BioCardia, Inc.
|
12.90M
|
Composite
44.0
Moat
11.5
|
4.03
+0.4
YoY
|
-137.9%
-113.5
YoY
|
|
LPCN
Lipocine Inc.
|
12.90M
|
Composite
53.2
Moat
38.4
|
18.36
-194.2
YoY
|
-5.2%
+5.1
YoY
|
|
12.83M
|
Composite
46.6
Moat
51.2
|
0.05
-0.2
YoY
|
-
No YoY
|
|
|
PASG
Passage Bio, Inc.
|
12.79M
|
Composite
49.8
Moat
31.2
|
17.63
-1.6
YoY
|
-
No YoY
|
|
12.74M
|
Composite
47.5
Moat
41.3
|
13.52
-17.9
YoY
|
-13.2%
+34.7
YoY
|
|
|
PAVM
PAVmed Inc.
|
12.60M
|
Composite
39.4
Moat
14.6
|
3.55
+3.1
YoY
|
-307.1%
-292.3
YoY
|
|
12.38M
|
Composite
44.9
Moat
41.5
|
15.41
-12.6
YoY
|
-5.8%
-4.1
YoY
|
|
|
GUTS
Fractyl Health, Inc.
|
12.33M
|
Composite
45.6
Moat
34.9
|
-
No YoY
|
-1005.7%
-582.1
YoY
|
|
BFRI
Biofrontera Inc.
|
12.30M
|
Composite
46.0
Moat
37.4
|
5.75
-1.2
YoY
|
-27.2%
+18.9
YoY
|
|
12.01M
|
Composite
46.4
Moat
20.0
|
6.71
+6.4
YoY
|
-
No YoY
|
|
|
11.96M
|
Composite
19.9
Moat
27.0
|
2.27
+1.0
YoY
|
-11.4%
-10.0
YoY
|
|
|
11.80M
|
Composite
48.3
Moat
16.4
|
6.85
+1.0
YoY
|
-
No YoY
|
|
|
RENB
Renovaro Inc.
|
11.60M
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
IRIX
IRIDEX Corporation
|
11.55M
|
Composite
43.6
Moat
45.2
|
34.20
+30.3
YoY
|
-4.9%
+12.2
YoY
|
|
FEMY
Femasys Inc.
|
11.47M
|
Composite
35.6
Moat
41.9
|
5.95
+3.8
YoY
|
-7.7%
+3.2
YoY
|
|
11.29M
|
Composite
47.7
Moat
33.4
|
10.97
-8.7
YoY
|
-
No YoY
|
|
|
11.22M
|
Composite
54.2
Moat
44.0
|
21.98
+17.4
YoY
|
-
No YoY
|
|
|
PPBT
Purple Biotech Ltd.
|
10.99M
|
Composite
53.7
Moat
31.5
|
20.31
+13.2
YoY
|
-
No YoY
|
|
10.84M
|
Composite
34.3
Moat
30.5
|
3.51
-6.5
YoY
|
-
No YoY
|
|
|
10.40M
|
Composite
41.2
Moat
14.6
|
5.80
+0.8
YoY
|
-14.7%
-3.4
YoY
|
|
|
10.34M
|
Composite
30.5
Moat
17.8
|
3.05
-12.9
YoY
|
-1.8%
+0.3
YoY
|
|
|
10.25M
|
Composite
52.5
Moat
36.7
|
6.80
-15.2
YoY
|
-13.1%
+32.0
YoY
|
|
|
10.20M
|
Composite
45.2
Moat
38.3
|
6.64
+5.2
YoY
|
-65.7%
-60.7
YoY
|
|
|
9.89M
|
Composite
55.4
Moat
30.8
|
10.57
+9.2
YoY
|
-9.9%
+122.3
YoY
|
|
|
9.80M
|
Composite
50.4
Moat
25.4
|
30.00
+26.8
YoY
|
-13.2%
+2383.8
YoY
|
|
|
9.79M
|
Composite
54.8
Moat
29.7
|
15.49
+13.5
YoY
|
-
No YoY
|
|
|
9.61M
|
Composite
45.1
Moat
16.8
|
4.75
-6.9
YoY
|
-56.5%
+26.1
YoY
|
|
|
9.56M
|
Composite
47.3
Moat
42.5
|
11.18
+0.0
YoY
|
-
No YoY
|
|
|
MTVA
MetaVia Inc.
|
9.42M
|
Composite
55.2
Moat
33.7
|
7.86
+0.1
YoY
|
-
No YoY
|
|
BLRX
BioLineRx Ltd.
|
9.35M
|
Composite
55.4
Moat
42.0
|
31.03
+25.7
YoY
|
-8.7%
+61.8
YoY
|
|
9.30M
|
Composite
42.0
Moat
33.2
|
12.01
-7.4
YoY
|
-107.1%
-84.7
YoY
|
|
|
9.30M
|
Composite
47.1
Moat
59.5
|
31.63
+22.5
YoY
|
-
No YoY
|
|
|
CALC
CalciMedica, Inc.
|
9.29M
|
Composite
49.3
Moat
21.6
|
7.38
-3.2
YoY
|
-
No YoY
|
|
9.16M
|
Composite
46.9
Moat
66.0
|
20.59
+17.5
YoY
|
28.2%
No YoY
|
|
|
INAB
IN8bio, Inc.
|
9.13M
|
Composite
55.6
Moat
44.5
|
25.57
+20.0
YoY
|
-
No YoY
|
|
AEON
AEON Biopharma, Inc.
|
8.77M
|
Composite
51.7
Moat
60.0
|
2.08
+2.1
YoY
|
-
No YoY
|
|
8.50M
|
Composite
40.9
Moat
28.6
|
4.69
+2.5
YoY
|
-
No YoY
|
|
|
GTBP
GT Biopharma, Inc.
|
8.00M
|
Composite
53.3
Moat
14.7
|
6.33
+2.7
YoY
|
-
No YoY
|
|
8.00M
|
Composite
42.5
Moat
47.7
|
27.79
+26.2
YoY
|
-46.5%
-43.0
YoY
|
|
|
7.70M
|
Composite
45.9
Moat
26.7
|
-
No YoY
|
-12.8%
-2.9
YoY
|
|
|
7.64M
|
Composite
49.8
Moat
29.3
|
9.40
+1.2
YoY
|
-
No YoY
|
|
|
7.51M
|
Composite
48.0
Moat
35.2
|
7.12
-3.0
YoY
|
-4.8%
+28.7
YoY
|
|
|
BMRA
Biomerica, Inc.
|
7.40M
|
Composite
37.2
Moat
33.1
|
4.59
-2.9
YoY
|
-1.2%
+95.5
YoY
|
|
7.40M
|
Composite
46.9
Moat
33.5
|
2.26
-13.6
YoY
|
-16.8%
-4.4
YoY
|
|
|
SNGX
Soligenix, Inc.
|
7.30M
|
Composite
48.2
Moat
16.8
|
9.28
-1.9
YoY
|
-57.0%
+335.8
YoY
|
|
7.30M
|
Composite
45.4
Moat
25.6
|
8.20
-14.7
YoY
|
-56.8%
+58.3
YoY
|
|
|
LTRN
Lantern Pharma Inc.
|
7.26M
|
Composite
48.6
Moat
25.1
|
7.75
-8.4
YoY
|
-
No YoY
|
|
7.10M
|
Composite
31.9
Moat
19.6
|
1.77
-3.5
YoY
|
-
No YoY
|
|
|
6.98M
|
Composite
45.8
Moat
36.2
|
79.79
+42.6
YoY
|
-16.3%
+18.5
YoY
|
|
|
FBLG
FibroBiologics, Inc.
|
6.81M
|
Composite
49.6
Moat
9.1
|
-
No YoY
|
-
No YoY
|
|
ALZN
Alzamend Neuro, Inc.
|
6.80M
|
Composite
48.2
Moat
5.7
|
1.06
-6.2
YoY
|
-
No YoY
|
|
IMRN
Immuron Limited
|
6.70M
|
Composite
52.9
Moat
54.6
|
5.53
-18.3
YoY
|
-49.9%
+23.4
YoY
|
|
6.52M
|
Composite
55.7
Moat
32.0
|
13.59
-6.6
YoY
|
-
No YoY
|
|
|
6.40M
|
Composite
47.6
Moat
12.1
|
6.63
+1.0
YoY
|
-
No YoY
|
|
|
6.39M
|
Composite
51.5
Moat
38.1
|
22.56
+13.7
YoY
|
-24.6%
-11.3
YoY
|
|
|
6.37M
|
Composite
52.2
Moat
29.6
|
6.89
+3.4
YoY
|
-
No YoY
|
|
|
6.30M
|
Composite
43.6
Moat
20.2
|
3.45
-7.5
YoY
|
-
No YoY
|
|
|
XCUR
Exicure, Inc.
|
6.22M
|
Composite
47.0
Moat
33.8
|
5.25
-46.3
YoY
|
-24.5%
-18.1
YoY
|
|
6.11M
|
Composite
41.0
Moat
26.6
|
9.09
+1.6
YoY
|
-93.9%
-87.1
YoY
|
|
|
PTHL
Pheton Holdings Ltd
|
6.01M
|
Composite
45.2
Moat
45.4
|
95.38
+54.3
YoY
|
-1.7%
+47.1
YoY
|
|
5.96M
|
Composite
32.9
Moat
29.6
|
4.02
+2.8
YoY
|
-3.0%
+0.5
YoY
|
|
|
5.94M
|
Composite
51.5
Moat
63.0
|
0.46
-4.6
YoY
|
-
No YoY
|
|
|
5.80M
|
Composite
43.6
Moat
27.0
|
1.69
-6.8
YoY
|
-
No YoY
|
|
|
LGVN
Longeveron Inc.
|
5.77M
|
Composite
48.1
Moat
29.6
|
3.00
-13.6
YoY
|
-19.4%
-12.5
YoY
|
|
5.73M
|
Composite
48.3
Moat
10.3
|
6.26
+1.7
YoY
|
-
No YoY
|
|
|
5.59M
|
Composite
62.0
Moat
15.8
|
13.36
+9.1
YoY
|
-
No YoY
|
|
|
5.40M
|
Composite
45.4
Moat
19.3
|
5.84
+4.6
YoY
|
-
No YoY
|
|
|
5.32M
|
Composite
44.0
Moat
38.9
|
7.32
-725.5
YoY
|
-12.6%
+13.4
YoY
|
|
|
AIMD
Ainos, Inc.
|
5.20M
|
Composite
37.3
Moat
34.8
|
1.09
-7.0
YoY
|
-112.7%
+555.0
YoY
|
|
5.13M
|
Composite
36.5
Moat
15.2
|
5.97
+5.7
YoY
|
-98.7%
+8.9
YoY
|
|
|
5.12M
|
Composite
42.0
Moat
37.8
|
11.45
-0.9
YoY
|
-24.6%
-12.5
YoY
|
|
|
XWEL
XWELL, Inc.
|
5.10M
|
Composite
37.4
Moat
35.8
|
3.61
-9.2
YoY
|
-53.6%
-4.4
YoY
|
|
PULM
Pulmatrix, Inc.
|
5.04M
|
Composite
49.2
Moat
52.1
|
9.03
-1.6
YoY
|
-1.3%
+0.8
YoY
|
|
4.98M
|
Composite
44.6
Moat
19.0
|
4.54
-9.5
YoY
|
-3126.3%
-3079.4
YoY
|
|
|
GELS
Gelteq Limited
|
4.92M
|
Composite
39.0
Moat
23.2
|
0.75
+0.5
YoY
|
-33.2%
+5.7
YoY
|
|
4.89M
|
Composite
50.5
Moat
27.4
|
10.71
-8.1
YoY
|
-437.4%
-197.6
YoY
|
|
|
4.82M
|
Composite
60.2
Moat
12.3
|
7.04
+2.2
YoY
|
-
No YoY
|
|
|
ACON
Aclarion, Inc.
|
4.78M
|
Composite
38.5
Moat
14.6
|
20.13
+19.1
YoY
|
-93.1%
+27.4
YoY
|
|
EVGN
Evogene Ltd.
|
4.75M
|
Composite
50.9
Moat
52.5
|
11.51
+2.2
YoY
|
-3.6%
-0.3
YoY
|
|
IMNN
Imunon, Inc.
|
4.74M
|
Composite
47.3
Moat
32.6
|
7.58
+3.8
YoY
|
-49.8%
-7.8
YoY
|
|
4.72M
|
Composite
47.2
Moat
38.1
|
3.34
+0.1
YoY
|
-132.5%
-16.2
YoY
|
|
|
4.68M
|
Composite
38.1
Moat
38.6
|
21.75
-9.0
YoY
|
-
No YoY
|
|
|
YCBD
cbdMD, Inc.
|
4.66M
|
Composite
43.1
Moat
38.2
|
18.68
-64.7
YoY
|
-11.3%
+5.8
YoY
|
|
TRIB
Trinity Biotech plc
|
4.63M
|
Composite
35.8
Moat
43.7
|
10.40
-4.4
YoY
|
-36.1%
-1.7
YoY
|
|
4.52M
|
Composite
45.3
Moat
23.5
|
0.83
+0.2
YoY
|
-2.3%
+19.1
YoY
|
|
|
AZTR
Azitra Inc
|
4.44M
|
Composite
46.7
Moat
17.6
|
2.21
-3.2
YoY
|
-1464.7%
-1453.8
YoY
|
|
4.42M
|
Composite
48.1
Moat
22.4
|
5.79
+3.2
YoY
|
-845.0%
-363.8
YoY
|
|
|
4.40M
|
Composite
52.8
Moat
24.4
|
7.17
-25.4
YoY
|
-
No YoY
|
|
|
4.38M
|
Composite
57.9
Moat
63.4
|
41.37
+15.1
YoY
|
-95.2%
-93.5
YoY
|
|
|
4.35M
|
Composite
43.9
Moat
46.0
|
6.61
-11.9
YoY
|
-1.4%
+72.6
YoY
|
|
|
MGRX
Mangoceuticals, Inc.
|
4.33M
|
Composite
36.6
Moat
18.9
|
3.05
+2.9
YoY
|
-39.5%
-26.6
YoY
|
|
ZCMD
Zhongchao Inc.
|
4.33M
|
Composite
42.8
Moat
41.4
|
106.6
-111.7
YoY
|
-54.4%
-52.3
YoY
|
|
MYNZ
Mainz Biomed N.V.
|
4.28M
|
Composite
28.4
Moat
37.2
|
4.38
+0.5
YoY
|
-20.9%
+8.8
YoY
|
|
4.17M
|
Composite
46.6
Moat
32.9
|
10.81
+3.5
YoY
|
-
No YoY
|
|
|
GRI
GRI Bio, Inc.
|
4.11M
|
Composite
49.8
Moat
12.7
|
9.69
+2.7
YoY
|
-
No YoY
|
|
4.10M
|
Composite
48.2
Moat
23.4
|
14.77
+1.3
YoY
|
-1023.8%
-501.6
YoY
|
|
|
3.90M
|
Composite
34.9
Moat
50.8
|
8.62
-0.0
YoY
|
-20.7%
+14.7
YoY
|
|
|
NCNA
NuCana plc
|
3.90M
|
Composite
55.1
Moat
36.6
|
38.97
+34.7
YoY
|
-
No YoY
|
|
3.86M
|
Composite
48.1
Moat
55.8
|
86.36
+23.8
YoY
|
-
No YoY
|
|
|
3.75M
|
Composite
53.8
Moat
39.4
|
34.50
+3.2
YoY
|
-
No YoY
|
|
|
CRIS
Curis, Inc.
|
3.72M
|
Composite
46.4
Moat
52.6
|
2.23
-3.8
YoY
|
-60.5%
-56.4
YoY
|
|
3.72M
|
Composite
56.7
Moat
27.2
|
6.46
+0.9
YoY
|
-
No YoY
|
|
|
3.50M
|
Composite
44.8
Moat
15.3
|
3.82
-12.5
YoY
|
-
No YoY
|
|
|
3.48M
|
Composite
33.6
Moat
29.1
|
8.30
+6.5
YoY
|
-1.7%
+93.9
YoY
|
|
|
TRAW
Traws Pharma, Inc.
|
3.40M
|
Composite
43.6
Moat
39.4
|
2.52
-6.1
YoY
|
-6.4%
+623.6
YoY
|
|
BCAB
BioAtla, Inc.
|
3.33M
|
Composite
52.5
Moat
40.7
|
1.77
-6.4
YoY
|
-29.7%
-22.9
YoY
|
|
3.30M
|
Composite
49.9
Moat
44.7
|
10.14
+5.7
YoY
|
-9.2%
-7.5
YoY
|
|
|
ICCM
IceCure Medical Ltd.
|
3.16M
|
Composite
43.2
Moat
32.1
|
7.33
+0.1
YoY
|
-4.5%
+0.3
YoY
|
|
3.11M
|
Composite
43.8
Moat
56.8
|
0.26
-3.7
YoY
|
-
No YoY
|
|
|
3.07M
|
Composite
52.6
Moat
27.3
|
11.64
+8.2
YoY
|
-
No YoY
|
|
|
3.07M
|
Composite
52.4
Moat
18.5
|
3.22
+1.9
YoY
|
-26.9%
+283.9
YoY
|
|
|
PRFX
PainReform Ltd.
|
3.05M
|
Composite
36.1
Moat
9.0
|
12.56
+8.5
YoY
|
-301.3%
No YoY
|
|
KALA
KALA BIO, Inc.
|
3.02M
|
Composite
48.7
Moat
34.1
|
2.83
-18.1
YoY
|
-21.0%
-9.4
YoY
|
|
MBIO
Mustang Bio, Inc.
|
3.00M
|
Composite
61.1
Moat
21.0
|
39.36
+32.2
YoY
|
-
No YoY
|
|
SNYR
Synergy CHC Corp.
|
3.00M
|
Composite
23.6
Moat
29.6
|
12.17
+10.5
YoY
|
-27.8%
-44.5
YoY
|
|
2.98M
|
Composite
28.4
Moat
21.2
|
6.84
-6.4
YoY
|
-
No YoY
|
|
|
2.90M
|
Composite
42.2
Moat
16.8
|
8.40
-3.2
YoY
|
-408.7%
-394.0
YoY
|
|
|
PHGE
BiomX Inc.
|
2.84M
|
Composite
40.8
Moat
51.4
|
1.98
-3.5
YoY
|
-
No YoY
|
|
2.82M
|
Composite
41.8
Moat
47.8
|
1.59
-4.1
YoY
|
-1.1%
-42.5
YoY
|
|
|
2.77M
|
Composite
35.7
Moat
21.9
|
5.54
+5.3
YoY
|
-70.5%
-29.9
YoY
|
|
|
ONCO
Onconetix, Inc.
|
2.74M
|
Composite
44.3
Moat
30.7
|
6.47
+5.7
YoY
|
-21.9%
+0.5
YoY
|
|
VCNX
Vaccinex, Inc.
|
2.68M
|
Composite
43.4
Moat
35.5
|
0.82
-0.0
YoY
|
-31.2%
+9.0
YoY
|
|
2.62M
|
Composite
41.2
Moat
23.6
|
10.24
+3.6
YoY
|
-37.4%
No YoY
|
|
|
VNRX
VolitionRX Limited
|
2.60M
|
Composite
36.6
Moat
60.2
|
0.68
-0.8
YoY
|
-12.6%
+9.3
YoY
|
|
2.59M
|
Composite
47.6
Moat
12.0
|
3.16
-2.7
YoY
|
-514.0%
-490.6
YoY
|
|
|
2.35M
|
Composite
49.6
Moat
13.0
|
14.16
-2.8
YoY
|
-
No YoY
|
|
|
2.29M
|
Composite
56.9
Moat
58.4
|
35.32
+31.4
YoY
|
-9.1%
+23.1
YoY
|
|
|
HCWB
HCW Biologics Inc.
|
2.28M
|
Composite
44.5
Moat
21.1
|
1.75
-2.2
YoY
|
-242.7%
-231.2
YoY
|
|
AKAN
Akanda Corp.
|
2.22M
|
Composite
25.6
Moat
13.5
|
0.90
-10.7
YoY
|
-19.3%
-10.7
YoY
|
|
2.21M
|
Composite
60.5
Moat
21.5
|
15.53
+11.3
YoY
|
-
No YoY
|
|
|
2.20M
|
Composite
34.0
Moat
12.4
|
4.94
-1.0
YoY
|
-27.8%
+41.6
YoY
|
|
|
2.20M
|
Composite
35.2
Moat
20.2
|
12.57
+0.7
YoY
|
-46.4%
-45.2
YoY
|
|
|
2.16M
|
Composite
40.9
Moat
44.4
|
0.13
-3.6
YoY
|
-25.8%
+1.0
YoY
|
|
|
2.15M
|
Composite
44.3
Moat
44.0
|
9.73
-9.4
YoY
|
-17.4%
-14.3
YoY
|
|
|
XAIR
Beyond Air, Inc.
|
2.10M
|
Composite
32.9
Moat
34.0
|
7.70
+5.5
YoY
|
-3.8%
+8.2
YoY
|
|
2.09M
|
Composite
55.4
Moat
42.1
|
2.65
-0.9
YoY
|
-7.7%
+8.3
YoY
|
|
|
ISPC
iSpecimen Inc.
|
2.05M
|
Composite
31.9
Moat
12.6
|
19.47
+16.7
YoY
|
-4.7%
-3.3
YoY
|
|
1.90M
|
Composite
46.9
Moat
25.6
|
3.28
-12.4
YoY
|
-43.5%
-14.7
YoY
|
|
|
NUWE
Nuwellis, Inc.
|
1.90M
|
Composite
36.0
Moat
44.1
|
1.20
-5.2
YoY
|
-1.3%
-0.1
YoY
|
|
1.89M
|
Composite
34.0
Moat
31.2
|
1.60
-4.3
YoY
|
-1.1%
+73.2
YoY
|
|
|
MLEC
Moolec Science SA
|
1.77M
|
Composite
46.7
Moat
51.7
|
0.83
-6.1
YoY
|
-31.2%
-35.4
YoY
|
|
1.76M
|
Composite
46.2
Moat
19.8
|
21.68
+17.5
YoY
|
-7.0%
-1.5
YoY
|
|
|
NXGL
NexGel, Inc
|
1.75M
|
Composite
29.9
Moat
37.6
|
2.90
-2.7
YoY
|
-29.3%
+11.6
YoY
|
|
1.70M
|
Composite
38.4
Moat
36.3
|
3.54
-15.3
YoY
|
-7.4%
-8.1
YoY
|
|
|
GNPX
Genprex, Inc.
|
1.70M
|
Composite
47.8
Moat
29.7
|
6.14
+5.1
YoY
|
-
No YoY
|
|
1.65M
|
Composite
52.3
Moat
28.0
|
3.75
-4.3
YoY
|
-
No YoY
|
|
|
KAPA
Kairos Pharma, Ltd.
|
1.65M
|
Composite
59.0
Moat
44.0
|
15.66
+11.8
YoY
|
-
No YoY
|
|
CODX
Co-Diagnostics, Inc.
|
1.60M
|
Composite
37.4
Moat
25.6
|
4.89
-7.3
YoY
|
-80.6%
-70.4
YoY
|
|
1.58M
|
Composite
53.4
Moat
44.1
|
6.63
-15.0
YoY
|
-
No YoY
|
|
|
OGEN
Oragenics Inc.
|
1.58M
|
Composite
55.7
Moat
35.1
|
10.90
+9.7
YoY
|
-
No YoY
|
|
1.44M
|
Composite
36.8
Moat
20.6
|
10.80
+2.4
YoY
|
-232.3%
-139.1
YoY
|
|
|
NKGN
NKGen Biotech, Inc.
|
1.44M
|
Composite
38.4
Moat
24.2
|
0.01
-0.0
YoY
|
-316.2%
-264.9
YoY
|
|
GOVX
GeoVax Labs, Inc.
|
1.44M
|
Composite
44.5
Moat
35.3
|
1.72
-1.0
YoY
|
-8.7%
-2.3
YoY
|
|
1.41M
|
Composite
50.6
Moat
43.9
|
18.69
+15.2
YoY
|
-2.2%
No YoY
|
|
|
ELAB
PMGC Holdings Inc.
|
1.30M
|
Composite
55.9
Moat
33.2
|
12.08
+3.4
YoY
|
-11.6%
-9.2
YoY
|
|
1.22M
|
Composite
35.2
Moat
42.5
|
9.01
-1.6
YoY
|
-27.8%
+18.1
YoY
|
|
|
1.20M
|
Composite
44.2
Moat
66.0
|
10.15
-0.1
YoY
|
-62.1%
+20.1
YoY
|
|
|
1.20M
|
Composite
44.4
Moat
37.3
|
6.84
+1.3
YoY
|
-21.7%
-14.0
YoY
|
|
|
LGMK
LogicMark, Inc.
|
1.17M
|
Composite
41.6
Moat
37.2
|
22.55
+11.8
YoY
|
-69.1%
+8.3
YoY
|
|
BBLG
Bone Biologics Corp
|
1.13M
|
Composite
48.5
Moat
33.5
|
23.79
+14.1
YoY
|
-
No YoY
|
|
TNON
Tenon Medical, Inc.
|
1.09M
|
Composite
40.2
Moat
33.9
|
4.19
-3.7
YoY
|
-3.2%
+1.0
YoY
|
|
IMCC
IM Cannabis Corp.
|
1.05M
|
Composite
32.4
Moat
37.5
|
9.62
+6.9
YoY
|
-21.2%
-2.2
YoY
|
|
1.00M
|
Composite
46.3
Moat
56.2
|
0.85
-2.5
YoY
|
-
No YoY
|
|
|
977,512
|
Composite
50.6
Moat
21.7
|
5.23
-7.9
YoY
|
-
No YoY
|
|
|
VSEE
VSee Health, Inc.
|
814,772
|
Composite
43.8
Moat
24.5
|
18.34
+17.7
YoY
|
-65.5%
-59.6
YoY
|
|
807,349
|
Composite
42.3
Moat
49.9
|
6.64
+4.9
YoY
|
-
No YoY
|
|
|
WORX
SCWorx Corp.
|
708,338
|
Composite
46.9
Moat
42.7
|
12.78
+11.6
YoY
|
-33.3%
+8.8
YoY
|
|
ADTX
Aditxt, Inc.
|
698,584
|
Composite
33.4
Moat
10.7
|
1.49
+0.9
YoY
|
-6125.4%
-5917.5
YoY
|
|
631,135
|
Composite
45.1
Moat
17.8
|
16.72
+5.6
YoY
|
-515.2%
+444.7
YoY
|
|
|
VERO
Venus Concept Inc.
|
563,314
|
Composite
30.2
Moat
51.2
|
4.63
-0.4
YoY
|
-41.9%
-4.9
YoY
|
|
500,000
|
Composite
41.6
Moat
30.8
|
20.54
+11.3
YoY
|
-17.2%
-0.5
YoY
|
|
|
NOTV
Inotiv, Inc.
|
476,223
|
Composite
38.4
Moat
36.8
|
24.95
-12.8
YoY
|
-6.0%
+11.6
YoY
|
|
IOBT
IO Biotech, Inc.
|
467,667
|
Composite
48.1
Moat
18.3
|
8.75
-15.2
YoY
|
-
No YoY
|
|
GCTK
GlucoTrack, Inc.
|
449,965
|
Composite
24.2
Moat
6.8
|
5.81
+0.4
YoY
|
-
No YoY
|
|
337,228
|
Composite
43.1
Moat
39.0
|
6.61
-0.3
YoY
|
-77.9%
-15.1
YoY
|
|
|
318,946
|
Composite
45.7
Moat
34.0
|
18.32
+16.7
YoY
|
-21.0%
-8.3
YoY
|
|
|
258,131
|
Composite
49.9
Moat
56.9
|
1.24
-2.1
YoY
|
-
No YoY
|
|
|
251,380
|
Composite
56.6
Moat
31.5
|
3.30
-0.4
YoY
|
-5.8%
+7.4
YoY
|
|
|
SPRC
SciSparc Ltd.
|
243,195
|
Composite
38.2
Moat
34.7
|
13.32
+8.5
YoY
|
-9.8%
-4.2
YoY
|
|
JAGX
Jaguar Health, Inc.
|
210,293
|
Composite
47.6
Moat
37.8
|
0.49
-2.8
YoY
|
-4.0%
-1.4
YoY
|
|
191,166
|
Composite
39.3
Moat
5.1
|
0.05
-2.1
YoY
|
-
No YoY
|
|
|
165,812
|
Composite
47.1
Moat
28.2
|
0.64
+0.4
YoY
|
-63.1%
-61.2
YoY
|
|
|
132,075
|
Composite
32.2
Moat
24.8
|
9.15
+1.2
YoY
|
-2.3%
+1.0
YoY
|
|
|
PRPH
ProPhase Labs, Inc.
|
94,043
|
Composite
30.5
Moat
18.1
|
0.13
-0.3
YoY
|
-4.2%
+1.6
YoY
|
|
92,946
|
Composite
36.9
Moat
54.8
|
0.00
-0.0
YoY
|
-
No YoY
|
|
|
VINC
Vincerx Pharma, Inc.
|
78,514
|
Composite
45.3
Moat
12.2
|
2.29
-1.5
YoY
|
-
No YoY
|
|
73,655
|
Composite
47.4
Moat
57.5
|
1.16
+0.5
YoY
|
-
No YoY
|
|
|
37,396
|
Composite
38.3
Moat
25.5
|
84.16
-8.4
YoY
|
-6.3%
-4.7
YoY
|
|
|
26,993
|
Composite
37.5
Moat
35.7
|
1.39
-2.5
YoY
|
-
No YoY
|
|
|
16,170
|
Composite
43.1
Moat
4.1
|
1.33
+0.2
YoY
|
-
No YoY
|
|
|
10,733
|
Composite
49.1
Moat
35.9
|
15.26
-4.5
YoY
|
-13.0%
-3.9
YoY
|
|
|
10,697
|
Composite
36.1
Moat
35.5
|
2.61
-9.2
YoY
|
-
No YoY
|
|
|
8,369
|
Composite
47.4
Moat
50.3
|
3.59
-7.9
YoY
|
-3.2%
+2.8
YoY
|
|
|
8,096
|
Composite
38.2
Moat
53.8
|
0.24
-2.2
YoY
|
-
No YoY
|
|
|
TTOO
T2 Biosystems, Inc.
|
5,609
|
Composite
29.0
Moat
5.9
|
3.91
+1.5
YoY
|
-6.9%
-4.4
YoY
|
|
2,485
|
Composite
36.1
Moat
20.6
|
1.09
-10.0
YoY
|
-
No YoY
|
|
|
ICCT
iCoreConnect Inc.
|
2,438
|
Composite
33.6
Moat
34.7
|
0.75
-0.9
YoY
|
-1.4%
-0.2
YoY
|
|
2,310
|
Composite
52.3
Moat
31.9
|
6.64
-5.9
YoY
|
-9.5%
+1.1
YoY
|
|
|
MSPR
MSP Recovery, Inc.
|
1,377
|
Composite
28.6
Moat
16.8
|
9.18
+5.7
YoY
|
-69.8%
+2.8
YoY
|
|
941
|
Composite
39.0
Moat
21.6
|
7.46
-4.7
YoY
|
-
No YoY
|
|
|
OTRK
Ontrak, Inc.
|
708
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
617
|
Composite
31.2
Moat
39.5
|
2.24
-2.1
YoY
|
-2.0%
-0.4
YoY
|
|
|
589
|
Composite
44.6
Moat
46.8
|
33.98
-122.9
YoY
|
-19.0%
+8.6
YoY
|
|
|
TRVN
Trevena, Inc.
|
479
|
Composite
41.6
Moat
33.4
|
11.98
+3.0
YoY
|
-11.3%
-146.2
YoY
|
|
BACK
IMAC Holdings, Inc.
|
379
|
Composite
27.4
Moat
17.8
|
1.91
+1.0
YoY
|
-78.0%
-7.8
YoY
|
|
DHAI
DIH Holding US, Inc.
|
209
|
Composite
44.2
Moat
48.6
|
0.21
-1.9
YoY
|
-7.7%
-3.7
YoY
|
|
-
|
Composite
62.8
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
ABPWW
Abpro Holdings, Inc.
|
-
|
Composite
42.6
Moat
43.6
|
0.13
-3.7
YoY
|
-54.2%
+42.1
YoY
|
|
ACCD
Accolade, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
59.8
Moat
58.4
|
-
No YoY
|
-
No YoY
|
|
|
ACONW
Aclarion, Inc.
|
-
|
Composite
40.5
Moat
14.4
|
20.13
+19.1
YoY
|
-93.1%
+27.4
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
53.6
Moat
27.3
|
-
No YoY
|
-139.2%
-103.3
YoY
|
|
|
AFMD
Affimed N.V.
|
-
|
Composite
41.9
Moat
43.1
|
-
No YoY
|
-12.9%
-10.8
YoY
|
|
-
|
Composite
37.7
Moat
34.3
|
1.09
-7.0
YoY
|
-112.7%
+555.0
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
ALLK
Allakos Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
ALVOW
Alvotech Warrant
|
-
|
Composite
41.3
Moat
55.3
|
41.20
+38.6
YoY
|
13.3%
-0.9
YoY
|
|
ALVR
AlloVir, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
AMED
Amedisys Inc
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
47.1
Moat
35.8
|
176.3
+134.0
YoY
|
-1.0%
+2.8
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
48.3
Moat
11.5
|
11.30
+0.4
YoY
|
-229.2%
-222.8
YoY
|
|
|
-
|
Composite
39.7
Moat
28.1
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
ATNFW
180 Life Sciences Corp.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
63.9
Moat
27.3
|
18.87
+9.1
YoY
|
-25.1%
-20.1
YoY
|
|
|
AVGR
Avinger, Inc.
|
-
|
Composite
27.9
Moat
22.9
|
-
No YoY
|
-2.2%
-0.2
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
33.0
Moat
37.9
|
-
No YoY
|
-3.0%
+1.5
YoY
|
|
|
-
|
Composite
47.9
Moat
33.5
|
23.79
+14.1
YoY
|
-
No YoY
|
|
|
-
|
Composite
56.8
Moat
58.6
|
0.43
-10.3
YoY
|
-
No YoY
|
|
|
-
|
Composite
44.9
Moat
47.6
|
1.59
-4.1
YoY
|
-1.1%
-42.5
YoY
|
|
|
-
|
Composite
49.2
Moat
37.4
|
5.75
-1.2
YoY
|
-27.2%
+18.9
YoY
|
|
|
BGNE
BeiGene, Ltd.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
37.8
Moat
29.1
|
8.30
+6.5
YoY
|
-1.7%
+93.9
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
BLUE
bluebird bio, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
61.5
Moat
51.3
|
-
No YoY
|
1.8%
+0.2
YoY
|
|
|
CANB
CAN B CORP.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
59.5
Moat
69.6
|
-
No YoY
|
9.4%
+1.2
YoY
|
|
|
-
|
Composite
59.8
Moat
70.6
|
-
No YoY
|
8.2%
+48.5
YoY
|
|
|
-
|
Composite
48.7
Moat
27.4
|
10.71
-8.1
YoY
|
-437.4%
-197.6
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
48.8
Moat
57.6
|
1.16
+0.5
YoY
|
-
No YoY
|
|
|
-
|
Composite
48.6
Moat
26.3
|
12.90
-6.2
YoY
|
-138.1%
-137.0
YoY
|
|
|
CELUW
Celularity Inc.
|
-
|
Composite
50.8
Moat
54.4
|
5.59
+4.2
YoY
|
-2.3%
+68.4
YoY
|
|
-
|
Composite
46.6
Moat
56.9
|
1.24
-2.1
YoY
|
-
No YoY
|
|
|
CHEK
Check-Cap Ltd.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
CINGW
Cingulate Inc. Warrants
|
-
|
Composite
59.5
Moat
11.5
|
7.62
-0.3
YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
CMRX
Chimerix, Inc.
|
-
|
Composite
46.9
Moat
26.9
|
-
No YoY
|
-455.5%
-168.3
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
CUTR
Cutera, Inc.
|
-
|
Composite
35.4
Moat
25.9
|
-
No YoY
|
-73.6%
-58.4
YoY
|
|
CYBN
Cybin Inc.
|
-
|
Composite
57.6
Moat
49.5
|
15.99
-20.4
YoY
|
-
No YoY
|
|
-
|
Composite
57.5
Moat
43.7
|
-
No YoY
|
-279.2%
-218.6
YoY
|
|
|
-
|
Composite
46.2
Moat
43.7
|
-
No YoY
|
-279.2%
-218.6
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
CYTHW
Cyclo Therapeutics, Inc.
|
-
|
Composite
35.3
Moat
18.8
|
-
No YoY
|
-18.6%
0.0
YoY
|
|
-
|
Composite
40.9
Moat
54.6
|
-
No YoY
|
-4.0%
-3.6
YoY
|
|
|
-
|
Composite
54.8
Moat
27.3
|
11.64
+8.2
YoY
|
-
No YoY
|
|
|
DRRX
DURECT Corporation
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
56.9
Moat
37.0
|
32.89
-3.3
YoY
|
-
No YoY
|
|
|
-
|
Composite
59.1
Moat
52.1
|
-
No YoY
|
-1.5%
+14.4
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
59.9
Moat
37.2
|
23.43
-35.8
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
EPIX
ESSA Pharma Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
40.5
Moat
13.2
|
3.11
-19.2
YoY
|
-
No YoY
|
|
|
ETNB
89bio, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
42.7
Moat
36.8
|
1.71
+0.3
YoY
|
-36.3%
-32.0
YoY
|
|
|
EVOK
Evoke Pharma, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
EYEN
Eyenovia, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
FNA
Paragon 28, Inc.
|
-
|
Composite
48.3
Moat
62.7
|
-
No YoY
|
-15.9%
+1.3
YoY
|
|
GBIO
Generation Bio Co.
|
-
|
Composite
52.1
Moat
48.8
|
25.10
-35.0
YoY
|
-7.2%
+16.3
YoY
|
|
-
|
Composite
23.0
Moat
24.6
|
-
No YoY
|
-85.3%
-84.3
YoY
|
|
|
GLYC
GlycoMimetics, Inc.
|
-
|
Composite
46.4
Moat
30.9
|
-
No YoY
|
-3927.5%
-3294.9
YoY
|
|
GNFT
GENFIT S.A.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
GOVXW
GeoVax Labs, Inc.
|
-
|
Composite
44.7
Moat
35.3
|
1.72
-1.0
YoY
|
-8.7%
-2.3
YoY
|
|
HLVX
HilleVax, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
31.1
Moat
18.2
|
2.68
+0.9
YoY
|
-1947.9%
-27.7
YoY
|
|
|
HUMAW
Humacyte, Inc.
|
-
|
Composite
44.0
Moat
25.0
|
5.77
+0.3
YoY
|
-53.1%
No YoY
|
|
ICAD
icad inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
30.4
Moat
13.7
|
3.84
-3.6
YoY
|
-47.1%
No YoY
|
|
|
IKNA
Ikena Oncology, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
IMAB
I-MAB
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
IMTXW
Immatics N.V.
|
-
|
Composite
53.3
Moat
51.2
|
31.89
-14.0
YoY
|
-3.8%
+21.0
YoY
|
|
INZY
Inozyme Pharma, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
53.9
Moat
34.9
|
4.46
-9.3
YoY
|
-
No YoY
|
|
|
KDLY
Kindly MD, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
KDLYW
Kindly MD, Inc. Warrants
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
53.6
Moat
21.4
|
0.26
+0.2
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
KRON
Kronos Bio, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
49.1
Moat
37.5
|
43.51
+37.5
YoY
|
-299.3%
No YoY
|
|
|
LEXXW
Lexaria Bioscience Corp.
|
-
|
Composite
46.6
Moat
37.7
|
2.26
-13.6
YoY
|
-16.8%
-4.4
YoY
|
|
-
|
Composite
41.4
Moat
45.5
|
2.07
-12.9
YoY
|
-4.0%
+9.2
YoY
|
|
|
-
|
Composite
61.1
Moat
33.3
|
19.96
+16.0
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
59.9
Moat
61.3
|
-
No YoY
|
-14.0%
+63.7
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
39.3
Moat
34.6
|
-
No YoY
|
-1.5%
-0.4
YoY
|
|
|
-
|
Composite
43.4
Moat
61.5
|
-
No YoY
|
14.8%
-0.3
YoY
|
|
|
-
|
Composite
49.3
Moat
51.7
|
0.83
-6.1
YoY
|
-31.2%
-35.4
YoY
|
|
|
MODV
ModivCare Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
MRUS
Merus N.V.
|
-
|
Composite
54.6
Moat
50.2
|
34.68
+4.8
YoY
|
-7.5%
-4.0
YoY
|
|
MSPRW
MSP Recovery, Inc.
|
-
|
Composite
30.3
Moat
16.7
|
9.18
+5.7
YoY
|
-69.8%
+2.8
YoY
|
|
MSPRZ
MSP Recovery, Inc.
|
-
|
Composite
30.3
Moat
17.0
|
9.18
+5.7
YoY
|
-69.8%
+2.8
YoY
|
|
MURA
Mural Oncology plc
|
-
|
Composite
55.9
Moat
29.7
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
52.7
Moat
43.6
|
51.66
-11.5
YoY
|
-10.0%
-6.2
YoY
|
|
|
NAOV
NanoVibronix, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
NARI
Inari Medical, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
NEUE
NeueHealth, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
51.5
Moat
23.7
|
0.83
+0.2
YoY
|
-2.3%
+19.1
YoY
|
|
|
-
|
Composite
44.9
Moat
24.1
|
0.01
-0.0
YoY
|
-316.2%
-264.9
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
NLSPW
NLS Pharmaceutics Ltd.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
41.5
Moat
56.8
|
0.26
-3.7
YoY
|
-
No YoY
|
|
|
-
|
Composite
41.3
Moat
39.1
|
6.63
+5.0
YoY
|
-13.2%
No YoY
|
|
|
NTRBW
Nutriband Inc. Warrant
|
-
|
Composite
53.0
Moat
44.1
|
10.69
-0.5
YoY
|
-4.1%
+0.7
YoY
|
|
NURO
NeuroMetrix, Inc.
|
-
|
Composite
36.6
Moat
33.8
|
-
No YoY
|
-2.9%
-1.7
YoY
|
|
NVRO
Nevro Corp.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
NXGLW
NexGel, Inc Warrant
|
-
|
Composite
32.2
Moat
36.8
|
2.90
-2.7
YoY
|
-29.3%
+11.6
YoY
|
|
NXLIW
Nexalin Technology, Inc.
|
-
|
Composite
35.2
Moat
43.6
|
9.01
-1.6
YoY
|
-27.8%
+18.1
YoY
|
|
OABIW
OmniAb, Inc.
|
-
|
Composite
64.8
Moat
54.5
|
17.78
-0.2
YoY
|
-3.7%
-0.9
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
36.1
Moat
51.5
|
-
No YoY
|
-1.9%
-3.0
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
50.6
Moat
40.0
|
-
No YoY
|
-53.1%
-23.0
YoY
|
|
|
ONMDW
OneMedNet Corporation
|
-
|
Composite
37.0
Moat
23.8
|
1.74
-3.5
YoY
|
-7.1%
+7.8
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
OPT
Opthea Limited
|
-
|
Composite
35.0
Moat
22.0
|
-
No YoY
|
-1538.9%
-152.4
YoY
|
|
OPTN
OptiNose, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
OTRKP
Ontrak, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
PAVMZ
PAVmed Inc. - Series Z
|
-
|
Composite
44.5
Moat
14.6
|
3.55
+3.1
YoY
|
-307.1%
-292.3
YoY
|
|
-
|
Composite
52.1
Moat
33.4
|
10.97
-8.7
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
PIIIW
P3 Health Partners Inc.
|
-
|
Composite
40.7
Moat
26.9
|
3.29
-0.9
YoY
|
-18.5%
+2.8
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
PRENW
Prenetics Global Limited
|
-
|
Composite
41.1
Moat
49.6
|
34.82
+8.7
YoY
|
-48.1%
-45.9
YoY
|
|
PROC
Procaps Group, S.A.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
PRTG
Portage Biotech Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
53.5
Moat
21.7
|
5.23
-7.9
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
QSIAW
Quantum-Si incorporated
|
-
|
Composite
41.3
Moat
49.2
|
20.64
-8.0
YoY
|
-47.7%
-12.2
YoY
|
|
-
|
Composite
46.2
Moat
21.4
|
15.53
+11.3
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
55.0
Moat
40.7
|
27.08
-22.2
YoY
|
-42.1%
-34.8
YoY
|
|
|
-
|
Composite
52.2
Moat
45.2
|
-
No YoY
|
-1.4%
+0.7
YoY
|
|
|
-
|
Composite
60.8
Moat
12.7
|
7.04
+2.2
YoY
|
-
No YoY
|
|
|
-
|
Composite
58.2
Moat
55.9
|
25.89
+18.6
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
51.3
Moat
30.1
|
20.54
+11.3
YoY
|
-17.2%
-0.5
YoY
|
|
|
SCLXW
Scilex Holding Company
|
-
|
Composite
23.4
Moat
26.1
|
2.27
+1.0
YoY
|
-11.4%
-10.0
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
SHLT
SHL Telemedicine Ltd
|
-
|
Composite
39.5
Moat
33.9
|
-
No YoY
|
-47.2%
-31.4
YoY
|
|
SLRN
ACELYRIN, INC.
|
-
|
Composite
37.2
Moat
44.4
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
43.2
Moat
50.1
|
6.64
+4.9
YoY
|
-
No YoY
|
|
|
-
|
Composite
54.0
Moat
69.8
|
-
No YoY
|
37.2%
+4.5
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
SRDX
Surmodics, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
SRZNW
Surrozen, Inc. Warrant
|
-
|
Composite
52.3
Moat
51.8
|
35.41
+11.9
YoY
|
-12.1%
-9.7
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
45.6
Moat
34.4
|
-
No YoY
|
-44.9%
+42.1
YoY
|
|
|
-
|
Composite
51.8
Moat
47.3
|
23.22
-50.0
YoY
|
-2.1%
+0.6
YoY
|
|
|
-
|
Composite
35.2
Moat
21.2
|
11.34
+9.3
YoY
|
-1321.5%
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
56.9
Moat
43.7
|
-
No YoY
|
-3.1%
+0.5
YoY
|
|
|
-
|
Composite
45.0
Moat
79.7
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
44.3
Moat
66.3
|
13.62
+11.1
YoY
|
-59.7%
-58.5
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
38.1
Moat
28.2
|
16.38
-6.1
YoY
|
-7.2%
+8.1
YoY
|
|
|
TRML
Tourmaline Bio, Inc.
|
-
|
Composite
47.3
Moat
60.4
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
TSVT
2seventy bio, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
44.1
Moat
33.3
|
16.20
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
40.3
Moat
27.7
|
16.15
-14.7
YoY
|
-
No YoY
|
|
|
VRNA
Verona Pharma plc
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
WGSWW
GeneDx Holdings Corp.
|
-
|
Composite
46.0
Moat
57.5
|
59.45
+50.8
YoY
|
-3.1%
+4.5
YoY
|
|
-
|
Composite
68.7
Moat
73.1
|
91.81
-9.6
YoY
|
97.6%
+101.5
YoY
|
|
|
-
|
Composite
70.0
Moat
73.1
|
91.81
-9.6
YoY
|
97.6%
+101.5
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
ZIMV
ZimVie Inc.
|
-
|
Composite
54.5
Moat
59.1
|
-
No YoY
|
-4.6%
+2.2
YoY
|
|
ZOM
Zomedica Corp.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
ZYXI
Zynex, Inc.
|
-
|
Composite
25.3
Moat
59.2
|
-
No YoY
|
3.1%
-2.7
YoY
|
Sector benchmarks show the distribution of key financial metrics across companies in Healthcare. Use them to contextualise individual company figures against the sector norm. The outer chart band shows the broader distribution, the middle band highlights the typical range, and the markers help separate the median from the average.